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TPSS Tao, Perdew, Staroverov, Scuseria density functional
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LJ Lennard-Jones (interaction)
HCO heme-copper oxidase
NOR nitric oxide reductase
rmsd root mean square deviation
ESP electrostatic potential
HOMO highest occupied molecular orbital
LUMO lowest unoccupied molecular orbital
NOTES:  
a) The cbb3-type oxidases are also referred to as the C-type oxidases in the thesis.
b) Amino acid numbers are written in format; CI:Arg323, where first letter corresponds to the 
enzyme subfamily (A, B or C-type); second roman numeral corresponds to the subunit number 
(I, II, III...etc.); last term after colon refers to the name and number of amino acid residue.
Abstract
Heme-copper oxidases terminate the respiratory chain in many eukaryotes and prokaryotes as 
the final  electron  acceptors.  They catalyze the  reduction  of  molecular  oxygen to water,  and 
conserve the free-energy by proton pumping across the inner mitochondrial membrane or plasma 
membrane of bacteria. This leads to the generation of an electrochemical gradient across the 
membrane, which is utilized in the synthesis of ATP. The catalytic mechanism of oxidase is a 
complex coupling of electrons and protons, which has been studied with the help of numerous 
biophysical  and  biochemical  methods.  The  superfamily  of  oxidases  is  classified  into  three 
different subfamilies; A-, B- and C-type. The A- and B-type oxidases have been studied in great 
depth, whereas relatively less is known about the molecular mechanism of distinct C-type (or 
cbb3-type) oxidases. The latter enzymes, which are known to possess unusually high oxygen 
affinity relative to the former class of enzymes, also share little sequence or structural similarity 
with the A- and B-type oxidases. In the work presented in this thesis, C-type oxidases have been 
studied using a variety of computational procedures,  such as homology modeling,  molecular 
dynamics simulations, density functional theory calculations and continuum electrostatics.
Homology models of the C-type oxidase correctly predicts the side-chain orientation of 
the cross-linked tyrosine and a proton-channel. The active-site region is also modelled with high 
accuracy in the models, which are subsequently used in the DFT calculations. With the help of 
these calculations it is proposed that the different orientation of the cross-linked tyrosine, and a 
strong hydrogen bond in the proximal side of the high-spin heme are responsible for the higher 
apparent oxygen affinity and a more rhombic EPR signal in the C-type oxidases. Furthermore, 
the pKa profiles of two amino acid residues, which are located close to the active-site, suggest a 
strong  electron-proton  coupling  and  a  unique  proton  pumping  route.  Molecular  dynamics 
simulations on the two-subunit C-type oxidase allowed for the first time to observe redox state 
dependent  water-chain formation in the protein interior,  which can be utilized for the redox 
coupled proton transfer.

Chapter 1
Introduction
Life on earth first appeared around 3.8 billion years ago in the form of a single-celled organism, 
which contained essential genetic and energy-generating machinery. Since then the basic form of 
life has continuously evolved into the more complex multi-cellular organisms of today. Under 
increasing  levels  of  atmospheric  oxygen and a  growth in  energy demands,  many organisms 
evolved in such a way that they switched their fermentation- or light-based energy production to 
highly efficient oxygen-based energy production, that is aerobic respiration.
Bioenergetics is a field of biochemistry that is concerned with the energy production in 
living  organisms,  which  is  fundamental  to  the  growth  and  development  of  any  organism. 
Bioenergeticists endeavors to explain how energy stored in light (hυ) or in chemical bonds of 
small  organic  compounds  is  converted  into  a  form  usable  in  cells,  such  as  Adenosine 
triphosphate  (ATP).  In  this  chapter  a  concise  introduction  of  the  synthesis  of  ATP through 
aerobic respiration or oxidative phosphorylation is given.
1.1 Oxidative phosphorylation
Adenosine  triphosphate  (ATP)  is  the  energy currency of  the  cell.  Hydrolysis  of  ATP yields 
adenosine diphosphate (ADP) and a molecule of inorganic phosphate (P i).  Due to excessive 
resonance stabilization of the orthophosphate group, the reaction is exergonic (ΔG° and ΔG<0), 
and releases energy ca. 7 kcal/mol under standard conditions. The free energy available is then 
spent in performing many metabolic biochemical reactions in the cell [1]. Hydrolysis of ATP 
also occurs to yield one molecule of adenosine monophosphate (AMP) and two molecules of 
orthophosphates. This exergonic reaction is also utilized to power biochemical reactions such as 
protein synthesis [1]. ATP is predominantly produced in all aerobic organisms by glycolysis, 
Krebs  cycle  and oxidative phosphorylation.  Relative to  the amount  of ATP produced during 
glycolysis and Krebs cycle, oxidative phosphorylation turns out to be the major source of energy 
in the cell [1].
In oxidative phosphorylation  the  reduced co-enzymes  NADH and FADH2,  which  are 
produced during glycolysis and Kreb's cycle, are oxidized. The electrons then traverse through a 
number of transmembrane (TM) protein complexes before being ultimately consumed in the 
reduction of molecular oxygen. Electron transport that takes place in oxidative phosphorylation 
is coupled to proton pumping across the inner mitochondrial membrane or plasma membrane of 
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bacteria, thereby generating an electrochemical gradient (Δμ) or proton-motive force (pmf). The 
Δμ  is  then  utilized  by  F1FO-ATP synthase  to  synthesize  ATP in  the  cytoplasm or  matrix  of 
mitochondria (Figure 1.1). The complete array of enzymes in the membrane is also commonly 
called the electron transport chain (ETC) or the respiratory chain (Figure 1.1). 
To quantify the ATP production during oxidative phosphorylation, H+/ATP or P/O ratios 
are usually examined. The H+/ATP ratio corresponds to the number of protons pumped across the 
membrane per ATP molecule synthesized, whereas the P/O ratio corresponds to the number of 
ATP molecules synthesized or Pi utilized, relative to the oxygen reduction (2 electrons per O 
atom). According to recent estimates H+/ATP is 10/3, whereas P/O is 2.3 or 1.4, depending upon 
if NADH or succinate is the electron donor [7]. 
The generation of electrochemical gradient due to the movement of electrons and protons 
from the  opposite  sides  of  membrane  was  first  suggested  in  1961 by Peter  Mitchell  in  his 
Chemiosmotic  hypothesis  [8].  According  to  Mitchell,  the  gradient  is  subsequently  used  in 
producing ATP through an ATP synthesis machinery [8]. After initial reluctance, the hypothesis 
was formally accepted.  However,  experimental data accumulated over the years suggest that 
respiratory complexes I and IV do not follow Mitchell's redox-loop mechanism (section 1.2, 
Figure 1.1) [9,10].
Figure 1.1 Schematic view of the electron transport chain (ETC) in mitochondria. Complex I (PDB id: 3M9S) [2]), 
complex II (PDB id: 1ZOY [3]), complex III (PDB id: 1KYO [4]), complex IV (PDB id: 1OCC [5]) and complex V 
(PDB id: 2XND [6]) are shown embedded in the lipid bilayer. Blue vertical arrows show the proton translocation 
across the membrane by the respiratory complexes, and red arrows show the electron transfer path. Other ancillary  
reactions are shown with black arrows. Suc, succinate; Fum, fumarate.
1.2 Respiratory complexes
In the following section a brief introduction to each member of the respiratory chain is given.
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Complex I is the first enzyme in the respiratory chain to receive electrons from NADH. 
Electrons then traverse through an array of metal-centers present in the hydrophilic arm of the 
enzyme before finally being consumed in the reduction of ubiquinone to ubiquinol (Figure 1.1). 
The movement of electrons and reduction of ubiquinone is coupled to proton-pumping across the 
membrane at a ratio of 4H+/2e- [11]. The recently solved crystal structure of complex I from 
Thermus  thermophilus and  yeast  Yarrowia  lipolytica has  shed  some  light  on  the  possible 
coupling between the electron transfer and proton translocation [2,12].
Complex  II  is  the  second member  of  ETC.  It  oxidizes  succinate  into  fumarate,  and 
electrons are eventually used in the reduction of ubiquinone to ubiquinol (Figure 1.1). A cofactor 
(FAD), chain of iron-sulphur clusters and a heme group are responsible for the intra-protein 
electron transfer. The enzyme is unique for two reasons; a) besides having a role in ETC, it is 
also active in  the Krebs cycle,  and  b) it  is  the only enzyme in ETC, in which intra-protein 
electron transfer is not coupled to any proton translocation [1].
Complex III functionality is based on a two-step Q-cycle mechanism [13,14], in which 
one of the two electrons from the oxidized ubiquinol is transferred to the mobile electron carrier  
cytochrome c, whereas the other one reduces a bound ubiquinone molecule. Subsequently, in a 
similar next step, another ubiquinol molecule is oxidized, which reduces another cytochrome c, 
and  the  bound ubisemiquinone radical (Figure  1.1).  Both  these  steps  are  coupled  to  proton 
translocation, which is stoichiometrically described as 2H+/2e-.
Since Complex IV is the main topic of the thesis work, it is described in detail in Chapter 
2, though functioning of complex V is briefly discussed here. Complex V is a biological rotor 
that is responsible for the coupling of Δμ to ATP synthesis [15]. The movement of protons down-
hill allows the rotation of membrane bound c-rotor (FO), which in turn rotates the central stalk 
located  inside  the  hydrophilic  domain  (F1).  This  causes  a  conformational  change  in  the 
nucleotide binding sites located in the F1  domain leading to the generation of ATP (Figure 1.1). 
Complex V is a reversible machine, such that, ATP hydrolysis can be utilized to pump protons 
across the membrane. Recent crystal structures have shown variations in the subunit composition 
of c-rotor, which has once again turned the debate onto the previously suggested P/O ratios [6].
ETC harnesses the energy available from the movement of electrons from low-potential 
(320 mV of NADH/NAD+) to high-potential (800 mV of O2/H2O), and couples it with proton 
translocation.  ETC in combination with ATP-synthase is  one of the most efficient  pathways 
available  in  aerobic  organisms  whereas,  anaerobic  organisms  make  use  of  other  metabolic 
pathways, such as fermentation. Moreover, instead of molecular oxygen as the terminal electron 
acceptor, other substrates such as sulphates or nitrates are used in the anaerobic respiration [1].
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Chapter 2
Respiratory complex IV
Complex IV or Cytochrome c Oxidase (CcO) safely converts molecular oxygen (O2) into water 
and couples  the free energy of  the reaction to  proton translocation across the membrane.  It  
consumes nearly all of the O2 available in cells, and contributes up to ~40% of the total  pmf 
generated  by  the  respiratory  chain.  In  this  chapter  the  structure  and  function  of  this 
'nanomachine' are described in detail, along with an introduction to the distinct cbb3-type CcOs, 
which are the main topic of the thesis. 
2.1 Molecular Oxygen
Molecular  oxygen  (O2)  constitutes  21%  (by  volume)  of  earth's  atmospheric  gaseous 
composition, and appears as a single most important molecule for the aerobic metabolism in 
prokaryotes and eukaryotes. In the respiratory chain,  O2  is converted into water and its  high 
oxidizing potential is utilized to generate energy in the form of ATP.  O2 exists in the triplet 
ground state (S=1), which is responsible for its paramagnetic nature and also its stability in the 
atmosphere despite its very high oxidizing potential. In order to overcome 'spin-forbiddenness' 
of the reaction of O2 with any molecular species, conversion of the triplet state into an  open-
shell singlet state (S=0), which is higher in energy by ca. 22 kcal/mol [16], is necessary. Various 
metal-containing protein systems (usually open-shell) overcome this limiting step by activating 
O2 through an electron transfer to it [17], and this mechanism is often explained in terms of spin-
orbit coupling [18].
The four electron reduction of O2 to two molecules of water can be a concerted or a 
stepwise  reaction  [19],  where  formation  of  the  first  species  O2-* (superoxide)  in  the  latter 
mechanism is thermodynamically unfavorable relative to the H2 oxidation (Em  = 0 mV) (Figure̊  
2.1). In addition to the 'spin-forbiddenness', negative redox potential of the first reaction is also 
responsible for the atmospheric inertness of O2. However, after the formation of one electron 
reduced species (O2-*), the subsequent one-electron reduction steps are relatively spontaneous 
(Figure 2.1), and Em  of the overall reaction from oxygen to water is ̊ ca. 800 mV. Addition of one 
electron at a time in a stepwise reaction also produces reactive oxygen species (ROS), such as 
HO* or O2-*, which are very strong oxidants [20].
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Figure 2.1 Stepwise one-electron reduction of O2 to water.  The standard redox potentials (at  25 °C and  pH=7) 
associated with each reaction are shown in Volts. The figure is based on references 21 and 22.
2.2 Cytochrome c oxidase (CcO)
Complex IV or cytochrome  c oxidase (CcO) catalyzes the reduction of O2 to water (Equation 
2.1). 
O2    +   8HN+ +   4e-  2H2O     +    4HP+ 2.1
The reaction is exergonic and free-energy available is utilized for proton-pumping across 
the inner-mitochondrial or bacterial membrane [21,23]. The four electrons required for reaction 
are supplied by the soluble (or membrane bound) electron carrier cytochrome c. The protons are 
transferred through well-defined proton channels that comprise polar amino acid residues and 
water molecules (Figure 1.1 and 2.2A) [21,23]. The substrate oxygen (O2) diffuses through the 
membrane  (Figure  1.1),  and  reaction  occurs  at  a  highly  conserved  active  site  formed  by  a 
bimetallic center (Fea3/CuB) (Figure 2.2B). The time length of the reaction is in milliseconds, and 
is  performed  with  high  efficiency  and  no  ROS  formation.  For  each  electron  and  proton 
consumed for oxygen reduction, a proton is pumped to the P-side of the membrane (HP+). The 
Δμ thus  contributes to the synthesis of ATP. In the sections below a general overview of the 
classification  of  oxidase  superfamily  is  given,  along with an  emphasis  on the  structure  and 
mechanism of oxygen reduction and proton pumping in CcO.
5
Figure 2.2 A) Structure of the A-type CcO from bovine heart mitochondria [50]. PDB id: 2EIJ. Subunit I (ice-blue), 
II (red) and III (gray, translucent) are shown in ribbon representations. Two proton channels and the electron transfer 
path are displayed with blue and red arrows, respectively. Few critical amino acid residues are also shown along  
with the metal centers. B) Binuclear center (BNC) formed by the high-spin heme (a3) and CuB, and the electron 
queuing low-spin heme (a), are shown in licorice representations. Hemes are in yellow color and CuB  in orange. The 
histidine ligands of  metals centers  are shown in blue color.  C) View from above the propionates  showing the 
propionate-protein interactions. The proton transfer paths, either to the BNC for oxygen reduction or to the proton-
loading site  (PLS) for  pumping,  are shown by the blue  arrows.  D)  Dimetallic  purple-copper  site  and  ligands.  
Selected hydrogen bonds are shown with purple dotted lines. Ligation to CuA site is shown with gray dotted lines. 
The amino acid numbering corresponds to the A-type oxidase from B. taurus.
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2.3 Family classification of heme-copper oxidases (HCOs)
All oxygen reductases, which contain heme-copper binuclear center are collectively known as 
HCOs. Due to  variations in their architecture and functionality, they are often classified into 
different subfamilies. The most common scheme for classification is based on the similarity of 
sequences  and other  functional  components  present  in  the  catalytic  subunit  [24,25,26].  This 
predominantly  led  to  three  different  HCO  subfamilies;  A-,  B-  and  C-type,  though  more 
elaborated  classifications  have  also  been  defined  [25].  However,  a  recent  study  has  argued 
against the further classification of HCO superfamily [27]. 
The majority of research work has been performed on the A-type oxidases, which are 
found in all three domains of life. The overall architecture of the enzyme varies between the 
prokaryotes and eukaryotes. The eukaryotic enzyme consists of additional regulatory subunits in 
addition to the homologous core subunits [28]. A-type oxidases are usually identified by their 
characteristic two proton channels (Figure 2.2A) and a conserved motif -GHPEVY- in subunit I 
[26]. Due to the large amount of literature available on A-type oxidases, their mechanism of 
oxygen reduction and proton pumping is described in detail in the subsequent sections.
The  second  subclass  comprise  B-type  oxidases,  which  are  predominantly  found  in 
archaea [24,25], and possess different structural and functional properties as compared to the A-
type  oxidases  [29,30,31].  For  instance,  recent  structural  and experimental  data  on  a  B-type 
oxidase  from  Thermus  thermophilus suggest  that  there  are  critical  differences  in  the  proton 
channel  architecture  and  in  the  mechanism  of  proton  pumping  with  respect  to  the  A-type 
oxidases [32,33]. Another fundamental difference between the B-type and A-type oxidases is 
that, in addition to oxygen reduction, B-type oxidases catalyze the reduction of nitric oxide (NO) 
to nitrous oxide (N2O), albeit at lower rates [34].
The third subclass is formed by C-type oxidases, which are discussed in detail in the 
sections below.
2.4 Evolutionary origins of HCOs
Several phylogenetic studies have raised the issue of evolution of HCOs. The earliest work by 
Castresana and Saraste suggested that the denitrification process (production of N2) preceded the 
aerobic respiration (reduction of O2) [35,36]. They proposed that C-type oxidases, which share 
relatively high structural similarity with the nitric oxide reductases (NORs) were the earliest 
HCOs, and existed even before the divergence of current forms of life. In their work, both A- 
and  B-  types  were  suggested  to  be  the  recent  oxidases,  which  evolved  as  the  oxygen 
concentration  in  atmosphere  increased,  whereas  C-type  oxidases  became limited  to  specific 
branches due to large-scale gene losses [35,36]. This hypothesis gains considerable support from 
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the experiments in which C-type oxidases are found to perform nearly efficient NO reduction 
[37]. Moreover, based on sequence analysis and catalytic efficiency it was suggested that the C-
type oxidases are evolutionarily primitive as compared to the more complex and efficient A-type 
oxidases  [24,26].  However,  recent  thorough  surveys  of  completed  genomes  have  found  a 
contrasting picture [38]. Since there are no archaeal prototypes for the C-type oxidases, and they 
are restricted to the proteobacteria kingdom only, such large-scale gene losses are unlikely to 
occur over the given timescales, and all three subfamilies have different evolutionary origins [38, 
39]. Further studies have also argued against the above hypothesis, and it was suggested that A-
type oxidases are primitive oxidases and were present even before the divergence of archaea and 
bacteria [40]. It has also been proposed that B-type and C-type CcOs are the results of horizontal 
gene transfers (HGT), such that few B-type oxidases were transferred from archaea to bacteria, 
whereas C-type oxidases from exclusive proteobacterial family to other bacterial families [40].
While  there  are  no  definite  answers  to  the  evolutionary  history  of  oxidases,  more 
thorough work is required in order to accept one of the hypothesis. A recent study reported by 
Pereira and co-workers led to the development of a database that consists of all the members of 
HCO  superfamily  (http://www.evocell.org/hco)  [41].  These  authors  reiterated  that  the 
classification of HCOs in three subfamilies (A, B and C-type) is conclusive [27,41]. 
2.5 Structural and functional aspects of A-type oxidases
With  the  advancement  in  techniques  of  membrane  protein  purification  and  crystallization, 
structures  of  A-type  CcOs  first  appeared  in  the  mid-nineties  [5,42].  Currently,  there  are 
approximately 50 structures available in the Protein Data Bank (PDB), that comprise oxidases 
from different organisms, in different redox or ligand-bound states, and at varying resolutions. 
These also include members from different subfamilies or closely related enzymes [30,43,44]. 
Although crystal structures have supported the previous mechanistic models, which were based 
on pure biophysical and biochemical experiments, their analyses have been unable to elucidate 
the underlying molecular mechanism of CcOs [45,46].
The first structure of A-type CcO obtained from bovine heart mitochondria was solved in 
1995 [47]. It is a multi subunit enzyme in which subunits I-III forms the catalytic core. These 
three subunits are also structurally and functionally conserved in all the bacterial CcOs [42,48]. 
The other subunits, which are unique to the mitochondrial oxidases possess regulatory functions 
[28] (section 2.6). The catalytic core is essential for the full activity of the oxidase (eq. 2.1), 
however,  a  two subunit  enzyme (I  and II)  has  also been successfully  reconstituted  into  the 
liposomes with near-native catalytic activity [49]. Figure 2.2A shows the overall architecture of 
the three subunit mitochondrial enzyme.
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2.5.1 Subunit I
2.5.1.1   Active-site
Subunit I is the largest subunit present in the enzyme and contains 12 TM helices arranged in a 
three-fold symmetry [5,42]. It harbors the active-site of oxygen reduction, which consists of a 
binuclear center (BNC) that comprises heme  a3 and CuB (Figure 2.2B). In the fully oxidized 
'resting' state of the enzyme, heme a3 is in high-spin (S=5/2) configuration and is ligated by a 
histidine ligand (AI:His376) on the proximal  side (Figure 2.2B),  and probably with a  water 
(H2O) on the other  [51].  Under  turnover  conditions,  it  most  likely remains  in  the high-spin 
configuration, although a hydroxyl (OH-) ligates from the distal side [52,53,54]. The propionate 
groups of the heme are held intact by the hydrogen bonding to conserved proteinaceous residues, 
and are thought to be critical in the proton pumping mechanism of CcO [21] (Figure 2.2C). In 
particular,  the  A-propionate  has  been suggested  to  form the  proton-loading site  (PLS)  from 
where the pumped protons are eventually released to the P-side [21]. 
The nearby metal center on the distal side of heme is CuB, and both metal sites are anti-
ferromagnetically coupled (S=2) in the fully oxidized state through a bridging ligand [55,56]. 
Based on the earlier crystal structures it was suggested that the two metal centers may have 
water/hydroxyl as non-proteinaceous ligands, and with a hydrogen bond between them, anti-
ferromagnetic coupling would be achieved that would cause no signal in the conventional EPR 
experiments [57,58]. Continuum electrostatic calculations also supported this observation [59]. 
However, high resolution structures and spectroscopic analyses obtained recently ascribes the 
electron-density between the metals to a peroxide-dianion (O--O-) bridge in the resting state of 
the enzyme [55,60]. Furthermore, structural and computational analysis of the BNC even led to 
the suggestions that bound ligand may either be a dioxygen molecule or a superoxide formed 
due to the X-ray radiation [54].
The  copper  center  CuB is  ligated  by  three  histidines;  AI:His240,  AI:His290  and 
AI:His291, one of which makes a covalent attachment to the conserved tyrosine (AI:Tyr244) 
(Figure 2.2B). The so-called cross-linked tyrosine is a unique feature known to exist in all the 
members  of HCOs. In the A-type oxidase it  is  located in  the helix VI of subunit  I,  and its  
phenolic oxygen hydrogen bonds with the hydroxyl of ethyl-farnesyl chain of heme a3 (Figure 
2.2A and 2.2B). Both, the hydrogen bond and the covalent linkage modulates the electron and 
proton affinities of the tyrosine and the BNC as a whole [61]. It has been suggested that tyrosine 
plays a crucial role in the initial steps of oxygen reduction chemistry by supplying a proton and 
an electron to the oxygenous ligand of heme a3 (see section 2.5.3) [62,63]. The fourth ligation 
site  of  CuB is  presumably occupied by a hydroxyl  or  a  water  molecule in  the oxidized and 
reduced case, respectively [59]. However, its true identity in turnover conditions still remains 
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unresolved [54,64,65,66].
Subunit I also contains an electron  queuing site, heme a, from which the electrons are 
transferred to the BNC one at a time (Figure 2.2A and 2.2B). The heme is low-spin (S=1/2), and 
is ligated by two absolutely conserved histidine ligands, AI:His61 and AI:His378 from helices II 
and X, respectively (Figure 2.2B). Similar to heme a3, strong ionic interactions exist between the 
heme-propionate groups and protein residues,  thereby modulating its  redox potential  (Figure 
2.2C).  It  is  known for  long  that  this  heme plays  an  important  role  in  the  proton-pumping 
mechanism of  CcO [67,68,69,70],  and  many  computational  studies  also  support  this  notion 
(section 2.5.3) [71,72,73]. 
2.5.1.2   Proton channels
The movement of electrons and protons in oxidase is a tightly coupled process. The electrons are 
transferred through the metal centers present in the enzyme, whereas protons are transferred to 
the BNC for oxygen reduction chemistry ('chemical protons') or to the P-side of the membrane 
for pumping ('pumped protons') through well-defined proton channels. Two such channels, D-
channel and K-channel, are named after conserved amino acid residues, aspartate (D) and lysine 
(K) (Figure 2.2A). 
The D-channel is structurally conserved in the A-type oxidases, where AI:D91 forms the 
proton-uptake site (Figure 2.2A). Mutation of AI:D91 in bacterial oxidases either to an alanine or 
an asparagine renders the enzyme with no pumping and with a very little catalytic activity [74]. 
From AI:D91 onwards the D-channel continues inside the protein through an array of conserved 
amino acid residues and water molecules. Many of these residues have also been mutated, and 
are  known  to  be  functionally  important  [75,76,77,78,79,80,81,82].  The  channel  eventually 
terminates at another highly conserved acidic residue; AI:Glu242 (Figure 2.2A and 2.2C). This 
residue is also conserved in all the A-type oxidases. The proton transfer path from AI:Glu242 
onwards, i.e. either to the P-side for pumping or to the BNC for oxygen reduction was unclear in 
the earlier crystal structures (Figure 2.2C). However, computational investigations suggested that 
dynamic water molecules might be present in the region above AI:Glu242, and could assist in 
proton transfer [83,84,85,86]. This proposal gained considerable support from the recent crystal 
structures in which a water molecule was indeed observed in the region [87]. The absence of 
water molecules in the region above glutamate is presumably due to the non-polar nature of the 
cavity, which causes high conformational entropy in the water molecules, consequently they fail 
to resolve with the conventional X-ray diffraction studies. AI:Glu242 has also been a subject of 
many experimental and computational studies [88,89,90,91,92,93,94,95]. Its side-chain which 
points  towards  the  N-side  ('down')  in  most  of  the  crystal  structures,  undergoes  rotational 
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isomerization during molecular dynamics (MD) simulations to form an 'up' conformation, from 
which it could release protons either to the BNC or to the P-side [92,94]. Recent crystal structure 
has  revealed  that  AI:Glu242 can  indeed form an 'up'  conformation  [96],  thereby supporting 
observations from the MD simulations. Based on biophysical experiments on the enzyme under 
steady state conditions, the pKa of glutamic acid has been found to be relatively high (>9), and it 
has  been  suggested  to  remain  protonated  throughout  the  catalytic  cycle  due  to  a  protonic 
equilibrium  with  the  N-side  (fast  reprotonation)  [97,98,99].  The  fast  isomerization  of  the 
deprotonated AI:Glu242 to its 'down' position has also been suggested to be critical in preventing 
proton-leaks [72,93]. Data from various experiments suggest that all pumped protons are taken 
from the D-channel  [99,100],  and that  it  also supplies  two protons  to  the BNC for  oxygen 
reduction [82].
The other channel is the K-channel, which is based on a conserved lysine (AI:Lys319) 
(Figure 2.2A), and transfers at most two protons to the BNC with no involvement in proton 
pumping [82,100]. The mutation of lysine to methionine has shown diminished electron transfer 
activity to the BNC, which suggests a critical role of this channel in proton transfer to the BNC 
[82].  The  mouth  of  the  channel  is  formed  by  a  conserved  acidic  residue  from  subunit  II, 
AII:Glu62 [101],  whereas  it  terminates  at  another  highly  conserved and crucial  residue,  the 
cross-linked tyrosine (Figure 2.2A). Due to lack of water molecules in the region from lysine to 
tyrosine,  it  has  been  difficult  to  envisage  a  continuous  proton  transfer  path.  However,  MD 
simulations on water-loaded crystal structure have shown the formation of stable water-chains, 
which  would  allow  efficient  proton-transfer  in  this  channel  [102].  A  strong  electrostatic 
interaction also exist between the lysine and the proton-uptake site, which may be important in 
redox-dependent proton transfer through this pathway [103]. 
2.5.2 Subunit II
Subunit II consists of two TM helices, and a β-sheet structure, which lies above subunit I in the 
hydrophilic  domain  of  the  membrane  (Figure  2.2A).  It  harbors  the  purple-copper  site,  a 
dimetallic  copper  center  (CuA),  which  receives  electrons  from  the  mobile  electron-donor 
cytochrome  c and donates them to the low-spin heme  a (Figure 2.2D and 2.2A). It has been 
suggested  that  a  charged  surface  near  the  CuA  site  is  responsible  for  the  tight  but  transient 
binding of cytochrome c, which would enable efficient electron transfer between the two [104]. 
A conserved tryptophan (AII:W104) has also been found to be critical in the bacterial oxidases 
for the electron transfer from cytochrome c to CuA [105]. As discussed in the previous section, a 
proton-uptake site (AII:Glu62) is also located in one of the TM helices of this subunit, which 
enables an uninterrupted supply of protons to the BNC [101].
11
2.5.3 Mechanism of oxygen reduction and proton pumping
The catalytic cycle of A-type CcO is shown in Figure 2.3, followed by a discussion.
Figure 2.3 Proposed catalytic cycle in the A-type CcOs. Various intermediate states are shown, with changes in 
oxidation states of low and high spin hemes, cross-linked tyrosine and CuB. Putative proton acceptors at BNC are 
shown along with the PLS protonated or deprotonated. Inwardly directed orange arrows show the electron input to 
heme a (from CuA). Inwardly and outwardly directed blue arrows show the uptake and release of proton from the 
PLS, respectively. Green arrows show the proton transfer to BNC. The first two protons to the BNC are supplied by 
the D-channel, whereas the last two protons are supplied by the K-channel (all green arrows). Two water molecules 
escape from the cavity in the R state, and dioxygen binds to form the state A. In each box the first Fe atom on the 
second line belongs to heme a and second Fe atom in the third line belongs to heme a3.
The reaction cycle shown in Figure 2.3 begins from a mixed-valence (MV) form of the 
enzyme (R) in which BNC is reduced, heme a and CuA are oxidized and PLS is deprotonated. 
Formation of MV state from the fully oxidized state (OH) is coupled to the uptake of two protons 
from solution, and electroneutrality of the BNC is maintained [106,107,108,109,110]. Molecular 
O2 binds weakly to the reduced heme iron (Fe[II]),  either replacing the bound CO or under 
physiological  conditions,  a  weakly  bound  water  molecule.  Since  experiments  are  usually 
performed on the CO poised enzyme, the CO is flash photolysed in the presence of oxygen and 
state A is formed [111], which can be described by an admixture of Fe[II]-O2/CuB[I] or Fe[III]-
O2-*/CuB[I] [112] (see below). In the latter arrangement, an electron transfer from the heme iron 
has activated the oxygen for further scission [17]. Based on spectroscopy measurements and 
chemically  constructed  active-site  models  of  CcO,  it  has  been  suggested  that  the  dioxygen 
molecule ligates only the heme iron, and does not form a 'µ-peroxo' bridge between the two 
metals Fe and CuB  [113,114]. However, the role of CuB[I] in enhancing oxygen binding to the 
heme has also been implicated [114]. The state  A has been found EPR (electron paramagnetic 
resonance) silent [112], which further suggests that either the low-spin heme iron is ligated with 
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a singlet oxygen as in Fe[II]-O2/CuB[I], or in the case of Fe[III]-O2-/*/CuB[I], low-spin heme iron 
is anti-ferromagnetically coupled with a doublet oxygen. Quantum chemical studies also suggest 
a  open-shell singlet ground-state for the intermediate  A [115,116,117]. Additionally, analogous 
studies on myoglobin like systems, in  which there is  no adjacent  copper  site,  also advocate 
similar electronic structure of the heme-oxygen system [118,119,120]. 
In the next 200 μs, an electron and hydrogen atom transfer takes place from the CuB and 
the cross-linked tyrosine, respectively, which results in the O-O bond cleavage. The state formed 
is  called  PM,  and  is  characterized  by  Fe[IV]=O2-,  CuB[II]-OH-  and  a  neutral  tyrosyl  radical 
(TyrO*) [121,122]. The cross-linked tyrosine plays a critical role at this stage of the reaction by 
providing an  electron  and a  proton.  Catalytic  importance  of  this  residue  is  known from its 
mutation to phenylalanine in the bacterial oxidases, which leaves the enzyme with no catalytic 
activity [123,124,125,126], whereas the chemical evidence for the existence of histidine-tyrosine 
cross-link comes from the mass spectrometric analysis [127]. Hence, all four electrons required 
for  the  reduction  of  O-O are  consumed from the  BNC itself,  i.e. two from iron  (Fe[II]  → 
Fe[IV]), one from copper (CuB[I] → CuB[II]) and another one from the cross-linked tyrosine (Tyr 
→ TyrO*). This reaction (A →  PM) is spontaneous and irreversible, and does not lead to the 
formation of any biologically toxic ROS. The state  PM is also EPR silent, with possible anti-
ferromagnetic coupling between the two metal-sites (Fe[IV]=O2-:S=2 and CuB[II]/TyrO*:S=1) 
[17,63]. The two hydrogen bonds, a) between the distal oxygen atom of oxo-ferryl species with 
the hydroxyl bound on CuB, and  b) between the phenolic oxygen of tyrosine and hydroxyl of 
ethyl-farnesyl  chain  of  heme  a3,  could  play  critical  roles  in  achieving such coupling.  In  all 
quantum chemical calculations performed on BNC models, such scenarios have been modeled 
and adequate  energetics  have  been obtained [128,129].  The transition from  A →  PM is  not 
coupled to proton uptake or proton pumping, while the high oxidizing potential of molecular 
oxygen is transferred to the enzyme in the form of high oxidation states of iron of heme  a3 
(Fe[IV]), copper (CuB[II]) and the tyrosine residue (TyrO*). Subsequent reduction of each center 
drives the proton-pumping mechanism in CcO. The four, one-electron reduction steps, PM → F, 
F → OH, OH → EH and EH → R are each coupled with a proton consumption at the BNC and 
proton pumping to the P-side via PLS (Figure 2.3).
As early as 1981 the intermediates of the O2 splitting reaction were first described by 
Wikström,  which  consisted  of  P (peroxy/OOH-)  and  F (oxo-ferryl)  intermediates  [130]. 
However, correct identities of these states became clear at a later stage when it turned out that in 
the P state, O=O bond is already broken, and it has an oxo-ferryl character [121,122]. Later on, 
experiments and subsequent modeling of the reaction from A → PM also suggested a presence of 
'peroxy' intermediate [131]. This state was called IP, and has not been observed experimentally 
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so far  due to  its  high energy and lower occupancy [131].   Furthermore,  based on quantum 
chemical  calculations,  the  likely  structure  of  IP intermediate  was  found  to  be  Fe[III]-
OOH-/CuB[II]/TyrO- (Figure 2.3) [128,129] and it was suggested that one electron each from the 
iron  and  copper  and  a  proton  from  the  cross-linked  tyrosine  has  been  transferred  to  the 
oxygenous ligand of heme to form the peroxide [128,129,131]. Even though the peroxy state IP 
has never been observed experimentally in the mechanism of HCOs, its possible existence has 
been shown in the cytochrome bd-type oxidases [132].
Each of the four proton pumping steps shown in Figure 2.3 are assumed to proceed in a 
similar  way.  However,  identities  of  the  final  electron  and proton acceptors  in  each step are 
different. During each pump step the free-energy differences diminish, such that proton pumping 
in the PM → F and F → OH transitions is thermodynamically more favorable compared to the OH 
→ EH and EH → R transitions. With the help of fast electron injection in the OH ('pulsed') state 
of the enzyme, combined with absorption spectroscopy and time-resolved electrometry,  OH → 
EH transition was studied in great depth and allowed the tracking of individual electron and 
proton  transfer  events  in  the  proton  pumping  mechanism of  A-type  CcO for  the  first  time 
[133,134]. This work led to the proposal of a pumping mechanism as described below, which 
would be valid for both bacterial and mitochondrial A-type oxidases [86,98,136].
A single electron injected into the enzyme (in OH state) equilibrates in 10 μs between the 
initial electron acceptor CuA and electron queuing heme  a  in the ratio of  30:70. At this stage 
there is almost no reduction of BNC due to its low redox potential. The slower proton uptake is 
not observed in this step due to the measurement of fast electron transfer from CuA to heme a. 
Nevertheless,  it  is  known that  redox potential  of  heme  a is  pH dependent  [135].  Next  the 
electron equilibrates between the heme a and BNC in 150  μs, in the ratio of 40:60. The mid-
point potential of the BNC is raised from its previous value most probably due to the loading of 
proton-loading site (PLS), which presumably lies closer to the BNC (or heme a3). The following 
slower phase of 800  μs (or nearly a ms) in which electron completely moves to the CuB and 
leaves all other redox centers oxidized is due to the high redox potential of CuB [133,134]. This 
huge increase in potential can be ascribed to the protonation of BNC. A last phase with a smaller 
amplitude corresponding roughly to 2.3 ms is also observed, which is most likely the release of 
proton from the PLS to the P-side [133,134]. Analysis of the potential generation across the 
membrane  identified  two  phases;  150  μs  and  800  μs,  which  corresponds  to  the  transfer  of 
'pumped'  and  'chemistry'  protons  to  the  PLS and  CuB,  respectively.  It  is  assumed  that  this 
pumping mechanism repeats four times, once for each transition.
Experimental data shows that heme a is the driving element in the pumping process of 
CcO with  its  equilibrium redox potential  being  pH dependent  [67,68,69,135].  However,  the 
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location of the site which would be protonated upon reduction of heme  a remains unknown. 
Based on theoretical modeling of experimental parameters [136] and computational calculations 
[137,138], it has been proposed that A-propionate of heme a3 is most probably the protonatable 
site upon reduction of heme a. It has also been proposed that PLS may not be just a single site 
but a cluster of residues on which the charge of a proton is smeared [98]. 
Assuming a tight coupling between the PLS and metal centers, the following sequence of 
events has been modeled in many different computational studies [72,86,93]. a) Upon reduction 
of heme a, PLS gets protonated through a proton-uptake from the solution (PM', F', OH' and EH' 
states in Figure 2.3), which in turn increases the redox potential of heme a3/CuB system due to its 
close proximity to the latter. This allows electron transfer from heme a to the BNC (PR, FR, OH,R 
and EH,R states in Figure 2.3), which is further coupled to another proton-uptake from the N-side. 
The charge compensation at the BNC, pushes out the proton from the PLS to the P-side of the 
membrane [136] (Figure 2.3). One of the critical aspects of this mechanism, which is based on 
thorough  experimental  findings,  is  that  the  'pumped'  proton  moves  to  the  PLS prior  to  the 
'chemistry' proton in the BNC. However, models have also been presented in which 'chemistry' 
proton is first transferred to the BNC [45].
2.6 Nuclear and mitochondrial coded subunits: Regulation
The A-type mitochondrial oxidases consist of three subunits coded by the mitochondrial DNA 
(subunits I-III) and 10 subunits  by the nuclear genome (subunit  IV-XIII).  The mitochondrial 
coded subunits  are  also present  in  the homologous bacterial  oxidases  (section 2.3),  whereas 
nuclear coded subunits are unique to the mitochondrial oxidases only, and play a critical role in 
the regulation of oxidase activity [139]. Specifically, the subunits IV and VI of A-type oxidase 
from  B. taurus are known to modulate the activity  of the oxidase,  which depends upon the 
[ATP]/[ADP]  ratio  in  the  mitochondrial  matrix  [140].  The  decrease  in  catalytic  activity  of 
oxidase upon higher  [ATP]/[ADP] ratio  is  either  achieved by reducing the H+/e- ratio  or by 
decreasing the affinity for electron-donor cytochrome c [140]. Allosteric inhibitory mechanisms 
have also been suggested to cause the modulation in activity of CcO when an ATP molecule 
binds to one of the accessory subunits [141]. Furthermore, phosphorylation of threonines, serines 
and tyrosines located on the matrix-side of the enzyme also probably alters the catalytic activity 
through an allosteric inhibition mechanism [140].
Currently, mitochondrial CcO is a subject of numerous studies due to its implications in 
neuro-degenerative disorders, mitochondrial diseases and other pathological processes, and has 
been approached via multiple experimental techniques. Moreover, it  is known to be the only 
enzyme in the mitochondrial respiratory chain that has tissue-specific isoforms in addition to 
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having developmental stage-specific isoforms [140]. This finding further highlights the medical 
importance of the enzyme.
2.7 cbb3- or C-type oxidases
The third dominant subfamily in the HCO kingdom is formed by the C-type oxidases, which are 
predominantly found in proteobacteria [142]. These high affinity oxidases are expressed in low 
oxygen tensions, and convert free energy of oxygen reduction to proton pumping with the same 
stoichiometry  as  their  A-type  counterparts  do  [143].  However,  recent  studies  provide  a 
contrasting picture by questioning the pumping stoichiometry of 1 H+/e-, and suggesting it to be 
only 0.5 H+/e- [144].
Initial biochemical experiments identified that these enzymes are encoded by an operon 
called fixNOQP (or ccoNOQP), which was named after the first isolation of these enzymes from 
the nitrogen-fixing bacteria [145,146,147]. This operon is always found upstream (towards the 5' 
end) to another operon called  cco/fixGHIS, which codes for the proteins responsible  for the 
assembly of oxidase [148]. The structural gene cco/fixNOQP encodes four subunits; N, O, P and 
Q. The largest subunit N shares the overall fold with the catalytic subunit of A-type oxidases 
(section 2.5.1). It consists of 12 TM helices and conserved histidine residues that ligate the metal 
centers (Figure 2.4A and 2.4B) [149]. The two other subunits (O and P) are unique to the C-type 
oxidases, and do not resemble any of the non-catalytic subunits of A- or B-type oxidases. The 
subunit  O consists of a TM helix and a cytochrome  c-type fold connected through a highly 
conserved linker (Figure 2.4A) [43]. The heme  c has methionine and histidine axial ligands, 
together with the covalently bound cysteines. The cysteines and histidine ligand together forms 
the highly conserved  CxxCH motif,  commonly found in the  c-type cytochromes [150].  The 
other non-catalytic subunit P consists of two cytochrome  c-type folds that are fused together 
through a conserved linker (Figure 2.4A) [43]. It also contains two conserved  CxxCH motifs, 
for  each  heme  c present  in  the  subunit.  The  smaller  and  less  conserved  subunit,  Q,  is  not 
important for the catalytic activity or for the assembly of the enzyme, but it has been suggested 
that it performs a protective role under oxic conditions [151].
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Figure 2.4 Crystal structure of C-type oxidase from P. stutzeri. PDB id 3MK7 [43]. A) Subunit I/N (ice-blue), II/O 
(red) and III/P (gray) are shown in ribbon representations, along with critical amino acid residues which form the 
putative proton channel. B) View from above the heme propionates show the metal ligands and other important 
residues surrounding the BNC. Metal-centers are shown in licorice representations; hemes in yellow, CuB in orange 
and calcium ions in pink. Selected hydrogen bonds are also shown as purple dotted lines. Amino acid numbering  
corresponds to the cbb3-oxidase from P. stutzeri.
It was found based on biophysical experiments that the catalytic subunit N consists of a 
low-spin electron queuing heme  b, and a BNC formed by high-spin heme  b3 and CuB [152], 
which are most likely arranged in a fashion that is similar to the A-type oxidases (section 2.5.1). 
Earlier studies also suggested critical differences in the active-sites of A- and C-type oxidases, 
especially as was found that binding of CO to heme b3 is more linear in the C-type oxidases, 
which was suggestive of a more 'open' BNC cavity [153]. Furthermore, CO recombination (post-
photolysis)  kinetics  was  also  observed  to  be  faster  in  the  C-type  oxidases,  and  thereby 
emphasizing varying active-site architecture in the two subfamilies [154,155].
The crystal  structure of C-type oxidase from  Pseudomonas stutzeri has recently been 
solved  [43].  Nevertheless,  computational  modeling  and  biochemical  experiments  performed 
prior to the crystal structure yielded valuable insights. Homology models of the  Rhodobacter  
sphaeroides enzyme  suggested  that  a  conserved  tyrosine  from  the  helix  VII  could  form a 
covalent attachment to the histidine ligand of CuB [126] (publication I,II). This role is performed 
by a tyrosine from helix VI in the A- and B-type oxidases. Later on, site-directed mutagenesis 
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studies, mass-spectrometric analysis and X-ray structure confirmed the presence of a histidine-
tyrosine  cross-link  as  predicted  (Figure  2.4A  and  2.4B)  [43,156,157,158].  Similarly,  the 
prediction of a proton channel in cbb3-oxidase (publication I) was confirmed by the mutagenesis 
studies and X-ray structure (Figure 2.4A and 2.4B) [43,156]. Based on the EPR measurements 
on wild-type and mutant enzymes in different redox states, it was found that a glutamate residue 
hydrogen bonds to the histidine ligand of heme  b3  [159], alike to the scenario in the catalytic 
triad of cytochrome c peroxidases ('Fe-His-Asp') [160]. The recently solved crystal structure also 
confirms this prediction (Figure 2.4B) [43]. 
The crystal structure shows some critical structural differences when compared to the 
structure  of  A-type  oxidases.  First,  distance  between  the  hemes  in  the  catalytic  subunit  is 
relatively shorter in the C-type oxidases, which would most likely alter the intra-heme electron 
transfer rates and the kinetics of oxygen trapping [43]. Second, the proteinaceous partners of 
heme  propionate  groups  are  also  different  in  the  C-type  oxidases  [43]  (Figure  2.4B).  In 
particular, the D-propionates of both hemes ligate to a single Ca++ ion, whereas in the A- or B-
type oxidases,  a pair  of  arginine residues  neutralizes the negative charge of  the propionates 
[42,43]. Furthermore, the proton channel identified in the location analogous to the K-channel of 
A-type oxidases is also structurally different (Figure 2.4A).
Based on mutagenesis studies it was suggested that B-type oxidases use a single channel 
for transferring both 'chemical' and 'pumped' protons [32]. Similar proposals have been made for 
the  cbb3-oxidases, which immediately leads to the question of evolution of proton channels in 
the  three  different  subfamilies,  and  in  particular,  about  the  proton  channels  responsible  for 
pumping.  C-type oxidases  also reduce NO [37],  but  do so without  coupling  the reaction  to 
proton pumping, and it has even been found that this catalytic reaction is not electrogenic, due to 
the uptake of both protons and electrons from the same side of the membrane  i.e. the P-side 
[161,162]. This also poses a question about the proton transfer path from the P-side, which could 
be utilized for proton pumping (in a reverse way). Furthermore, biophysical experiments found 
that the redox potential of heme  b3 is uniquely low (-60 mV), in sharp contrast to the  Emo of 
analogous heme in the A-type oxidases [135,159]. Though some structural reasons for this stark 
difference  have  been  identified,  it  further  raises  questions  about  the  differences  in 
thermodynamics of electron transfer in the two enzyme subfamilies.
In many bacteria that belong to the  Helicobacter genus and  Campylobacter  genus,  the 
electron transport chain terminates at the C-type oxidases as the sole electron acceptors [163]. 
These bacteria are known to be responsible for many pathological conditions,  which in turn 
presents a unique and novel scenario for the targeted drug design.
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2.8 Nitric oxide reductases
Nitric oxide reductases (NORs) form another family of enzymes that are responsible for the 
reduction of  nitric  oxide (NO) to nitrous oxide (N2O). These enzymes share local  sequence 
similarities with the C-type oxidases (ca. 18% for the catalytic subunit) and are also capable of 
reducing O2 to  water,  albeit  at  lower rates  [164,165,166].  The NOR enzyme comprises  two 
subunits, one heme c containing subunit NORc, which is analogous to the subunit O of the C-
type oxidases, and the main catalytic subunit which comprises heme  b and  b3-types. Heme  b3 
along with a non-heme Fe forms the EPR-silent dinuclear center in which the catalytic reaction 
takes place. The structure of the NORbc complex from Pseudomonas aeruginosa has recently 
been solved at 2.7Å resolution [167], and shows high local structural similarity with the structure 
of C-type oxidase from Pseudomonas stutzeri. The dinuclear active site contains a non-heme Fe, 
which has an unusual glutamate residue ligation, in addition to the three histidines. The presence 
of a charged amino acid near the dinuclear center causes low redox potential of the heme  b3 
[167]. It has also been proposed recently that heme b3 is in low-spin configuration, contrary to 
the popular perception of it being high-spin [168]. The catalytic reaction leads to the formation 
of N-N bond in N2O, which requires two electrons and two protons along with two substrate 
(NO) molecules. It has been observed that the reaction is not electrogenic, and both protons and 
electrons are taken from the P-side of the membrane [169,170]. The recently solved structure of 
enzyme also reveals that the proton uptake channels from the N-side, which are active in the C-
type oxidases, are not conserved in NORs, whereas there are traces of proton pathways from the 
P-side [167].
19
Chapter 3
Multiple sequence alignments and homology modeling
Currently there are about 20,000 unique entries in the Protein Data Bank (PDB), calculated after 
removing redundant protein sequences with 50% or above similarity.  On the other hand, the 
'RefSeq' database (http://www.ncbi.nlm.nih.gov/RefSeq/) at the National Center for Biological 
Information (NCBI) lists 13,137,813 protein sequences obtained from nearly 16,000 organisms. 
Despite the advancements in the methodologies of genomics and proteomics, this shows that the 
protein structure data lags behind the sequence data. In order to overcome this huge gap, protein 
structure prediction methods play a crucial role, and are commonly used in the field of drug 
discovery  or  de-novo protein  design.  In  this  chapter  a  brief  introduction  to  the  methods  of 
multiple sequence alignments and homology modeling is given.
3.1 Sequence alignments
Sequence  alignments  provide  multiple  solutions  in  the  realm  of  protein  or  gene  sequence 
analysis. They help in the identification of homologous sequences, their comparison, validation 
and phylogenetic analysis, and structure modeling. Classically, pairwise sequence comparisons 
were performed with the help of 'dot-plots' [171], where two sequences were aligned on a two-
dimensional  matrix  and amino-acid matches  were observed on the  diagonal.  However,  such 
methods provided redundant comparisons, and gaps (insertions and deletions) were not taken 
into account explicitly, which resulted in suboptimal alignments.
Currently, pairwise sequence alignments are performed by using two methods:  global  
alignment and local alignment. Global alignments are suited for two sequences that are similar 
in  length  and  have  relatively  high  similarity,  whereas  local  alignments  are  more  useful  in 
identifying the regions of local similarity in two divergent sequences. Local alignments are often 
more difficult to perform.
Two sequences can be optimally aligned with the help of global alignment methodology 
implemented in the Needleman-Wunsch method [172]. This method is based on the 'dynamic 
programming' approach, in which maximum value of the alignment score is achieved based on 
the  predefined  substitution  matrix,  gap  and  gap-extension  penalties.  Although  robust,  this 
method is slow, particularly when large sequence data have to be analyzed. On the other hand, 
the Smith-Waterman algorithm, which is a variation from the Needleman-Wunsch algorithm, can 
be reliably used to obtain local alignments in the cases of low sequence similarity [173].
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However,  due  to  the slower performance of  aforementioned methods,  faster  heuristic 
methods have been developed which are capable of treating larger sequence data [174]. These 
heuristic approaches are based upon the progressive alignment techniques in which pairwise 
alignments of more similar sequences are first generated, and then based on phylogenetic tree 
constructions more divergent sequences are aligned [174,175]. Since accuracy of an alignment 
falls with the increase in divergence between the sequences, other constraints can be used to 
generate  initial  pairwise  alignments  as  accurately  as  possible.  It  has  been  suggested  that 
sequence identity of less than 30% may lead to large errors in an alignment [175]. Therefore, 
newer methods have been proposed, which often yield alignments of high quality. Two such 
methods are,  iterative refinement  and consistence scoring [176,177,178,179].  In  the iterative 
refinement procedure the alignment is broken down into smaller subsets and re-alignments are 
performed until the score is optimized. For the consistence scoring method, the initial scoring is  
performed by taking multiple sequences into account, rather than just two.
CLUSTAL [180] and T-COFFEE [179] are popular sequence alignment programs based 
on progressive alignment techniques.
3.2 Structural alignments
It is well-known that a protein structure can remain conserved during the evolution, even though 
variations  may  occur  in  its  sequence.  Structural  alignments  take  into  account  the  three 
dimensional structure of a protein and have been shown to greatly improve the quality of the 
sequence  alignment  [175],  specially  in  the  cases  of  distantly  related  proteins.  Web-based 
methods such as Basic Local Alignment Search Tool (BLAST) [181] can also be adjusted to take 
into account the structural information during the sequence search. CLUSTAL and 3D-COFFEE 
[182] too provides a methodology that generates multiple sequence alignments by including 
structural  information.  The  high  gap  and  gap-extension  penalties  in  structurally  conserved 
regions  do  not  allow  insertions  to  occur,  whereas  in  the  loop  regions  such  insertions  and 
deletions occur freely due to lower sequence and structural homology.
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Figure  3.1  Figure  showing multiple  sequence  alignment  of  subunit  I  from A,  B and C-type  oxidases.  A-type 
oxidases from Bos taurus (B_t),  E. coli (E_c), and  Sulfolobus acidocaldarius (S_a); B-type from T. thermophilus 
(T_t)  and  A.  ambivalens (A_a);  and  C-type  from  R.  sphaeroides (R_s),  C.  jejuni (C_j)  and  H.  pylori (H_p). 
Additionally, a caa3-type oxidase from T. thermophilus is also shown in the alignment.
22
3.3 Protein Structure Prediction
The tertiary or  quaternary structure  of  a  protein determines  its  function.  Hence,  in  order  to 
understand its biochemical operations, a high resolution structure is often required. The most 
commonly  used  methods  for  protein  structure  determination  are  X-ray  crystallography  and 
Nuclear Magnetic Resonance (NMR). Both these methods are time consuming and expensive in 
order to be used for each of the protein sequence available. Furthermore, problems associated 
with the protein purification, low yields, and impurity of samples, makes the task of structure 
determination especially challenging for the membrane proteins. In addition, the static nature of 
X-ray structures and technical difficulties associated in resolving the structure of high-energy 
intermediates necessitates the use of protein structure prediction methods, which strive to model 
the protein structures as close to their native states as possible.
According to the classical definition, protein structure prediction methods can be broadly 
divided into three different categories;  a) Template-based modeling (Homology modeling),  b) 
Fold-recognition and c) ab-initio or de-novo or free modeling [183]. However, all three methods 
are sometimes used in tandem in specific cases of protein modeling [183,184]. To serve large-
scale protein structure prediction endeavors, such as modeling of all the members of G-protein 
coupled receptors (GPCRs), requires web-based automated servers [185]. These servers are often 
based on the above listed methods or some combination of them. They are also capable of 
generating protein models with minimal manual intervention, and have shown great success in 
the recent Critical Assessment of protein Structure Prediction (CASP) experiments [186]. Based 
on the CASP results over the years, the most successful method for protein structure prediction 
is the template- or homology-based modeling [187,188]. Both web-based and standalone tools 
are available to perform the homology-based modeling.
3.3.1 Homology modeling
Homology  modeling  is  based  on  the  principle  that  two  proteins  that  share  a  common 
evolutionary origin are homologous to each other, and may also have a high structural similarity. 
The sequence of the protein for which a three dimensional structure is sought (target sequence), 
is modeled by using the structural information obtained from the homologous protein (template), 
aided with the sequence alignment between the two. The sequence and structure of the template 
protein can be optimally determined with the help of many web-based tools [179,189]. The most 
commonly used method is BLAST, or its variants, in which a target sequence is submitted as a 
'query', and the complete sequence database is searched. Based on the search results, possible 
templates are identified along with a pairwise or multiple sequence alignment. Fold-recognition 
methods are also based on the similar principles, in which a model of the target sequence is 
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constructed, in addition to the identification of template(s). The Fold-recognition methods make 
use  of  pre-defined  sequence-structure  relationships  [190,191].  Many  web-based  servers  that 
perform either task of template search or fold-recognition are available [192,193], and a number 
of programs are listed here: http://www.russelllab.org/gtsp/foldrec.html.
In homology modeling sequence alignment between the target and template sequences 
play a critical role. It has been suggested that at least 40% sequence similarity is required, in 
order to generate quality homology models [194]. In the case of lower sequence similarities 
(known as 'Twilight zone'), an optimal alignment is often difficult to obtain, and main-chain and 
side-chain positions are likely to be modeled incorrectly [195]. It is often necessary to generate 
larger multiple sequence alignments in order to obtain optimal alignments between the template 
and  target  sequences.  This  allows  clear  identification  of  regions  of  high  and low sequence 
conservation [192]. Additional input of structural information in the form of constraints is also 
known to increase the success rate of homology modeling [175].
A general protocol of the homology modeling process can be described as follows, and 
may require repetition and manual intervention at different stages; 
a) generation of structural alignment of the available template structures,
b) alignment of template sequence(s) to the structural information from a),
c) generation of a larger multiple sequence alignment that contains target sequence and other 
homologous sequences,
d) addition of the alignment c) to b) through different methods of sequence-to-profile or profile-
to-profile alignments.
Finally, from the larger alignment (step d above), the target-template sequence alignment 
is  fed  into  the  homology  modeling  program  for  structure  generation.  Profile-to-profile 
alignments have successfully been used in the past for homology-based modeling. They tend to 
improve the identification of deviating patterns in the multiple sequence alignment [196,197]. 
Many different algorithms exist that construct a model for a given target sequence. Some 
popular  algorithms  implemented  into  programs  are;  satisfaction  of  spatial  restraints 
(MODELER)  [194],  segment  matching  (LOOK)  [198],  rigid-body  superposition  (SWISS-
MODEL) [199] and artificial evolution (NEST/JACKAL) [200,201].
3.3.1.1 MODELER: Model building and validation
MODELER is one of the most popular programs for homology-based modeling. Many recent 
surveys have found its enhanced performance over a diverse set of proteins [202,203]. Apart 
from having  a  fully  automated  model  generation  protocol,  MODELER also  allows  manual 
intervention,  which  could  be  used  to  improve  the  quality  of  the  models.  In  recent  CASP 
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experiments, manual interventions have been shown to improve the success rate of homology 
models [204,205,206,207,208].
MODELER requires a target sequence, template-target sequence alignment and template 
structure as inputs for the automated model generation procedure. In difficult cases of modeling, 
such as when the target-template sequence identity is low (<40%), experiment based input in the 
form of distance or angle constraints, along with modified MODELER parameters, may improve 
the quality of models. MODELER works on a principle that is similar to the concept of distance 
geometry, and combines it with an energy function optimization, which can be compared with 
the common forcefield-type potential energy function optimization [194]. A brief description of 
MODELER's functionality is described next.
During a single run of MODELER, 'features' such as, bond lengths, bond angles, main-
chain and side-chain dihedrals, Cα-Cα or N-O distances, etc. are built depending on the template 
structure  and  template-target  sequence  alignment. These  features  are  then  transformed  into 
conditional probability density functions (pdfs or pi), which depend upon the residue type, main-
chain conformations, equilibrium values, gaps between residues,  etc. The conditional  pdfs are 
further combined into a single function P (of the form, Πpi) and different types of optimizations 
are performed. Optimization of the function  F (= lnP), with respect to Cartesian co-ordinates, 
yields  a  final  model.  The  lower  value  of  MODELER's  objective  function  (F)  means  lower 
number of violations in geometry, and this model is more precise among an ensemble of models 
that are generated. This process can be repeated, and also be combined with the changes in the 
alignment, especially in the regions of low sequence conservation. Such manual interventions 
are often required to increase the quality of the models.
Figure  3.2  MODELER's  objective  function 
value  vs number  of  optimization  steps.  10 
optimization cycles are performed to obtain a 
final  model.  Each  cycle  consists  of  a 
Conjugate  Gradient  optimization  of  the 
variable  target  function,  followed  by 
Molecular  Dynamics  Simulated  Annealing 
protocol.
After the homology models have been constructed, different quality checks and structure 
validations  are  performed  in  order  to  identify  potential  stereo-chemical  errors,  errors  in 
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backbone dihedrals, planarity of rings, side-chain packing, atomic contacts, etc. Many different 
programs  exist  for  this  purpose;  Procheck,  Molprobity  and  Anolea,  to  name  a  few 
[209,210,211,212].  Depending  upon  the  results  of  the  quality  check,  different  types  of 
refinements can be performed including more accurate forcefield based energy minimization and 
molecular  dynamics  [213,214,215].  With these refinements,  the quality  of the model  can be 
improved, though its accuracy is not guaranteed. Currently there are no methods that would 
identify 'near-nativeness' of a constructed model. It has often been observed that the structure of 
a modeled protein is more similar to the template, than to its own native structure. The likely 
reasons for this are the problems associated with the modeling protocols. Despite this, recent 
CASP experiments have shown progress in this field, where near-to-native models were indeed 
obtained especially in those cases in which sequence similarity between target and template was 
high [188]. Along with the improvements in modeling methodology, validation tests have also 
evolved over time. In recent CASP exercises, modeled proteins were subjected to an ensemble of 
validation tests, which led to the identification of many false positives [205].
3.3.1.2 MODELER: Problems and Loop modeling
Homology  models  are  sometimes  rendered  inaccurate  due  to  errors  in  the  template-target 
sequence alignment. More specifically, the most variable parts of the alignment i.e. the loops, are 
often  modeled  incorrectly  in  which  the  side-chain  conformations  are  predicted  erroneously. 
Furthermore, most of the spatial-restraint violations also occur in such regions in MODELER 
calculations (publication I).  In these cases,  it  is  often advisable to combine data  from other 
sources to the homology modeling program e.g. in the form of distance or angle constraints. 
When no other data are available, the modeling of loops can also be performed de-novo 
[216], in which loops are modeled by using forcefield based methods, or by searching possible 
templates from available libraries. Knowledge-based methods have also been highly successful 
in predicting correct side-chain dihedrals.  These methods are often used in conjunction with 
homology modeling,  in which side-chains are  modeled by using side-chain rotamer libraries 
[217].  Both  backbone-dependent  and  backbone-independent  rotamer  libraries  are  available 
[217,218]. 
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Chapter 4
Density functional theory
The last two decades have seen a substantial growth in the use of Density Functional Theory 
(DFT) in modeling biochemical problems. This has been possible due to the higher accuracy and 
lower  computational  cost  of  DFT,  relative  to  many  ab-initio methods.  The advent  of  novel 
algorithms, highly parallelized programs and increase in computational power have enabled the 
routine treatment of metal-containing biological systems up to hundreds of atoms. One hybrid 
density functional (B3-LYP) has dominated the field of biomolecular computations due to its 
superior performance in calculating accurate energetics of the reactions. In this chapter, basic 
principles of DFT, its functionality and performance are briefly discussed.
4.1 Early ideas in DFT
Early work by Fermi and Thomas led to the foundations of DFT [219,220]. In their theoretical 
model kinetic energy (T) of the system was expressed as a functional  F of electron density or 
particle density ρ(r).
T=F [r ] 4.1
where r =∫* dv and Ψ is the wavefunction. 4.2
However, their model failed to provide a greater accuracy due to the incomplete description of 
kinetic energy and exchange energy, and absolute omission of electron correlation. Later work 
by Hohenberg and Kohn laid the foundations of contemporary DFT calculations [221], by which 
it was suggested that if ground state electron density of a system is known, the minimal energy 
and other properties can be readily evaluated.
4.2 Formulation of DFT
DFT, though inherently different from Hartree-Fock (HF) theory, still share substantial similarity 
with the latter. In the sections below, basic formulation of DFT is briefly discussed along with 
the critical differences to HF theory.
4.2.1 The Schrödinger equation and the Self-consistent Field method
The Schrödinger equation after Born-Oppenheimer approximation [222] can be written as,
∑i −ℏ
2
2me
∇ i
2−∑
i , A
Z A
riA
∑
i , j
1
r ij =E 4.3
Here, the first term from left corresponds to the kinetic energy of electrons, the second term 
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corresponds to the Coulombic interaction between the electrons (i) and nuclei (A), and third term 
is the electron-electron interaction. Physical constants and Coulombic interaction between nuclei 
are omitted for simplicity. Solutions of eq. 4.3 are readily available if the third term is ignored, 
which  would  correspond  to  no  electron  interaction.  Energy  (E)  in  such  a  case  is  high  and 
incorrect, and is equal to the sum of energies of individual electrons. Moreover, the solutions (Ψ) 
are  eigenfunctions  of  individual  uncorrelated  electrons,  known  as  the  Hartree  Product. 
Therefore, explicit treatment of the last term is thus necessary in order to obtain the correct  E 
and Ψ, which complicates the solutions of eq. 4.3 in a multi-electron system (i>1). All methods 
such as DFT, HF or post-HF, which aim to provide solutions to the multi-electron Schrödinger 
equation (eq. 4.3), are based upon the self-consistent field (SCF) method. In this method the 
wavefunction (Ψ), which is expressed in a Slater-determinant formalism [223], is varied until the 
energy of the system is minimized below a given threshold value.
Equation 4.3 results in two 'two-electron energy' terms. The first two-electron integral is 
a Coulombic integral Jij, and represents the repulsion between two electrons,
J ij=∑
i
∑
j
∫∫iri2 1r ij
 jr j
2 dv i di dv j d j 4.4
In HF theory Ψi(ri) are the spin-orbitals, and in DFT (Ψi(ri))2 is the electron density (see eq. 4.2). 
The second two-electron integral is the Exchange integral (Kij), which appears in HF theory only.
K ij=∑
i
∑
j
∫∫iriir j 1r ij
 jr j j ridv i didv j d j 4.5
It has been observed that this term provides a correction to the over-estimated Coulombic term 
(eq. 4.4), but does not capture the electron correlation effects compared to the DFT or post-HF 
methods [222].
The total energy in HF method is thus given by,
E=∑
i
hi∑
i
∑
j
J ij−K ij  4.6
and, in DFT,
E=∑
i
hi∑
i
∑
j
J ijEXC [r ]
4.7
All terms in eq. 4.7 are the functions of electron density. The first term on the right (hi) 
collectively represents the kinetic energy of electrons in a non-interacting system (T), along with 
the nuclei-electron interaction (V). The second term is the classical Coulombic electron-electron 
interaction (U) and the third term contains all the remaining contributions for which the exact 
formulation remains unknown. If the last term exchange correlation energy (EXC) is known, the 
exact energy of the system can be obtained. It is understood that EXC comprises of contributions 
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from  kinetic  energy  (in  an  interacting  system),  in  addition  to  exchange  and  correlation 
contributions [224].
4.2.2 Kohn-Sham (KS) orbitals
The  equation  4.7  is  solved  with  the  use  of  Lagrange  multipliers  under  the  constraint  that 
integration of electron density over space yields a total number of electrons in the system. This  
yields KS equations,
f i
KSi=ii , where f is the one electron operator
f i
KS= hi∑
j
J ij V XC  
The KS equations are solved iteratively until the predefined threshold is reached. The 
required  initial  density  is  usually  constructed  from the  simpler  methods  such  as  Extended-
Huckel method [225] or from the lower level of theory. It has been recognized that final  Ψ 
obtained after solving analogous HF equations does not represent the correct wavefunction due 
to the missing electron correlation. In such a case it is more like a non-interacting system, and 
energies reported are also not exact [224]. In the case of DFT, approximate functions are used to 
describe the exchange-correlation potential, VXC. These approximations (section 4.4) have given 
impressive results and current research in the field of DFT is primarily aimed at improving the 
formulations of VXC. The solutions of KS equations are known as KS orbitals (Ψi) [226], which 
are inherently different from the HF orbitals, though their use in calculating different properties 
of molecules to a high accuracy has been reported [227,228,229]. 
 
4.3 Basis sets
The spatial part of spin-orbital r ,w=r w can be expanded as a Linear Combination 
of Atomic Orbitals (LCAO),
lr =∑
m
c lmm
where clm are the coefficients and Φm  are the basis functions [222,230].  Φm  are not necessarily 
orthogonal, but may be normalized. During a SCF iteration, energy of the system is minimized 
by varying the coefficients until thresholds for change in energy and coefficients are reached.
Earlier basis functions were analogous in formulation to the hydrogenic atomic orbitals, 
and were called as Slater-type orbitals (STOs) [231]. However, Gaussian-type of orbitals (GTOs) 
were later preferred [232], due to the complications in solving two-electron integrals (eqs. 4.4 
and 4.5). The GTOs can be expressed as,
r1−rc =N x1−xc
i y1− yc
j z1−zc 
k e−r1−r c
2
Here N is the normalization constant, x1, y1 and z1 are the co-ordinates of electron, xc, yc and zc are 
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co-ordinates of the center, i, j  and k are the non-negative integers and α is a positive exponent. 
Multiple  GTOs are  often  added together  to  approximate  a  single STO, a  process  known as 
'contraction' [233,222]. For example, a STO approximated by n GTOs can be written as,
r i
STO−nG=∑
n
d i nnr 
The contraction coefficients din and the exponential constant α are usually obtained after 
iterative refinement procedure [222]. When compared to the simpler and less accurate STO-nG 
type of basis sets, split-valence (SV) type of basis sets are currently used more often. In SV basis 
sets, core and valence electrons are treated separately. One such commonly used basis set is 6-
31G*  (Pople  notation  [234,235,236]).  In  this  notation  the  first  number  corresponds  to  the 
number of basis functions (or gaussian primitives) used to define the core electrons e.g. the 1s 
orbital. The last two digits denote the number of two separate contraction schemes that are used 
to treat the valence electrons. For example, 3 Gaussian primitives, and separately 1 Gaussian 
primitive for the valence electrons (2s orbital onwards). These basis functions are often added 
with polarization (*) and diffuse functions (+) in order to provide a more realistic description of 
chemical bonding [236].
4.4 DFT: Exchange Correlation (XC) functionals
In HF or post-HF methods the results can be improved systematically by increasing the size of 
the basis set or by increasing the level of theory. However, there exist no systematic way of 
improvement in DFT, and quality of results mainly depends upon the formulation chosen for 
EXC.
4.4.1 Local (Spin) density approximation (LSDA)
This is the most basic type of approximation for XC functional. If the electron density varies 
very slowly (uniform electron gas), the EXC
LDA can be written as,
EXC
LDA=∫r eXC dr or  in  the  case  when  system  has  unpaired  electrons  (open-shell 
system),
EXC
LSDA=∫r eXC dr
where e XC  is the exchange-correlation energy per particle weighted with the density  ρ(r) 
[226]. In metal systems or in proteins, in which the variations in electron density are far more 
drastic,  the  LDA  fails  to  give  satisfactory  results  [237,238].  For  example,  when  this 
approximation  is  used  in  calculating  the  thermochemical  data  on  the  G2  set  of  molecules, 
average error as much as by 36 kcal/mol is observed in the energies [239]. However, it performs 
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satisfactorily in evaluating the equilibrium structures and frequencies of molecules [224]. The 
commonly used DFT functionals associated with L(S)DA approximation are; S-VWN [240] and 
PW-LDA [241]. 
4.4.2 Generalized gradient approximation (GGA) or meta-GGA functionals
Inclusion of the gradient of density (∇) into the functional led to a great improvement in the 
results [224]. Energy in this case is given by,
EXC
GGA=f  , ,∇ ,∇  dr
while in the case of meta-GGA,
EXC
meta−GGA=f  , ,∇ ,∇  ,∇
2,∇
2dr
Here second derivatives  (∇2) are also included in the calculations. The well-known functionals 
associated  with  GGA  are  B-LYP,  B-P86  [242,243,244],  whereas  with  meta-GGA;  TPSS 
[245,246,247]. 
4.4.3 Hybrid functionals
The EXC in hybrid density functional also consists of the exact exchange interaction calculated 
from the HF theory (eq. 4.5). One of the most popular hybrid density functional is B3-LYP 
[243,248,249],
EXC
B3LYP=1−a0EX
LSDAa0 EX
HFaXEX
B88ac EC
LYP1−aC EC
VWN
where constants a0, ax and ac are 0.2, 0.72  and 0.81, respectively. Each of them were obtained by 
fitting the calculated heat of formation of small molecules to the experimental data [249]. The 
EXLSDA describes 80% exchange interaction in a fully interacting system, whereas 20% comes 
from the HF theory. ΔEXB88 is the gradient correction to the exchange term, and ECLYP and ECVWN 
consists of the correlation and its gradient correction, respectively. 
4.5 Functionality in DFT
4.5.1 Coulombic term
The one-electron integrals  are  calculated in  a  similar  way in both HF theory and DFT, and 
computational demand for these integrals is also relatively low. However, the most demanding 
calculation is the numerical computation of two-electron integrals (eqs. 4.4 and 4.5). In the HF 
method, these integrals are explicitly evaluated, whereas in the DFT, the inherent separation of 
the  Coulombic  and Exchange terms  in the  form of  J and  EXC simplifies  and speeds-up the 
calculations. Furthermore, the Coulombic term is handled by the methods of density fitting in 
DFT, where M4 dependency is reduced to M2N by the use of auxiliary basis sets [250,224]. Here, 
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M is the number of basis functions, and N is the dependency of density that is obtained when 
atom-centered basis functions are replaced with an approximate density (eq. 4.2). This has been 
shown to provide a speed-up of one order of magnitude with little loss of accuracy [251]. In a 
popular  DFT program,  TURBOMOLE [252],  this  approach is  used as  'resolution-of-identity 
(RI)-J, where J stands for Coulombic term [224]. Other DFT codes also utilize similar methods. 
Moreover,  many other  advanced grid-based or  grid-free  numerical  integration methods have 
been developed and are used in many DFT codes [224].
4.5.2 Solvation effects in DFT
Solvation effects are usually modelled by mimicking the dielectric continuum of proteins. A 
commonly used methodology is the Conductor-like screening model (COSMO) [253]. In this 
method the solvent is treated in a scaled conductor manner such that the polarization of the 
solvent due to the solute is modelled by scaling the screening charges on the cavity surface by a 
factor of f =
−1
0.5
 , where  ϵ is the dielectric constant. The interaction energy between the 
solute and the scaled surface charges is then evaluated and optimized during the SCF iterations. 
The cavity surface can be represented by the Van der Waals surface of the molecular system. 
The COSMO solvation model  has  been implemented  in  many quantum chemistry  programs 
[253,254,255] and  adequate results have been obtained for both high and low dielectric systems 
[253,254,255]. 
4.6 Performance of DFT
The power of DFT lies in eq. 4.2, which allows the reduction of dimensionality of the problem 
by expressing 3N Cartesian co-ordinates of electrons into just three spatial variables of density.
4.6.1 Geometry optimization
Highly accurate molecular structures and ground-state energies have been obtained based on the 
geometry optimizations using DFT [256,257,258,259]. It has been observed that the basis set 
requirements are not stringent in the DFT-based geometry optimizations. However, at least split-
valence (SV) or triple-zeta valence (TZV) quality basis sets are recommended to achieve high-
quality  results  such as in  transition metal  containing systems [256].  On the  other  hand,  the 
choice of the functional has been found to be critical. The performances of GGA (BP86) and 
meta-GGA functionals (TPSS) are superior to the commonly used hybrid functional B3-LYP, 
especially in the case of first-row (3d) transition metal containing systems [260,261,262,263]. 
The GGA functional BP86 is a popular choice of method for geometry optimizations due to its  
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high  computational  performance  (section  4.5.1).  Recent  research  has  also  shown  the 
improvement  in  quality  of  optimized  structures  with  the  newer  meta-GGA  type  TPSSh 
functional, which incorporates 10% exact exchange [260].
4.6.2 Enzyme mechanism modeling
Due to its high accuracy and low computational cost, DFT has been the workhorse of enzyme 
mechanism modelling. Large cluster model systems of the enzyme active sites that contain ca. 
200 atoms have been used in the DFT calculations in order to assess the energetics of reaction 
[264]. It has been shown that with a sufficiently large cluster model a convergence in energies 
can  be  obtained  [264,265,266].  However,  universal  application  of  this  approach  has  been 
debated, and it has been found that the convergence with the system size is slow to achieve 
specially  in  comparison  to  the  hybrid  quantum  mechanics/molecular  mechanics  (QM/MM) 
approaches,  which  are  also  often  more  accurate  [267].  In  the  field  of  enzyme  mechanism 
modelling,  the  performance  of  hybrid  density  functional  B3-LYP  has  been  found  to  be 
exceptionally superior compared to the GGA functionals such as BP86 or PBE [268]. However, 
errors in relative energies of up to 5 kcal/mol have also been reported for the transition metal 
containing systems [268]. For the G2 reference set of molecules, the errors in energies are in the 
range of 2-3 kcal/mol of the experimental values [268,269]. A higher accuracy is sought in the 
energetics of an enzyme mechanism modelling, which puts a lower limit on the quality of basis 
sets to be used. At least TZV quality basis sets are recommended, which could be added with the 
polarization or diffuse functions [270]. 
4.6.3 Problems associated with DFT
Despite  the enormous success,  DFT calculations also suffer with the errors.  The three most 
commonly occurring errors in the DFT calculations are: a) Self-interaction error, b) errors due to 
the missing static correlation, and c) errors due to the missing van der Waals interactions [268]. 
Self-interaction errors beyond the one-electron case still  remains enigmatic.  However,  recent 
developments  have  highlighted  their  sources,  and  improvement  in  density  functionals  is  an 
active research field [224]. The errors in static (non-dynamical) correlation stems from the fact 
that DFT is  a single determinant based method, whereas in cases for which near-degenerate 
determinants  are  required  to  define  the  ground  state,  multi-configurational  SCF  (MC-SCF) 
methods are the popular choice [256]. It has also been suggested that the B3-LYP functional is 
designed to take care of these two errors, such that they cancel each other out in some cases 
[268].
The  errors  sourcing  from  the  incomplete  treatment  of  van  der  Waals  interaction 
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(dispersion), results in the inconsistencies that are observed during geometry optimizations or 
single-point calculations. Since these interactions are quantum mechanical in nature, and can be 
considered  similar  to  the  exchange  interaction  of  HF  theory  (attractive  dispersion)  [271], 
empirical  corrections  to  DFT  energy  have  been  applied.  These  corrections  have  shown 
improvements in the structure quality and energetics [271].
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Chapter 5
Continuum electrostatics
Continuum electrostatic calculations provide a solid and efficient means to calculate the pKa of a 
titratable  residue  in  a  protein.  As  the  name  implies,  the  solute  (protein),  and  the  solvent 
surrounding the solute i.e. either the membrane or the aqueous phase, are modeled as continua 
with fixed dielectric constants. The Poisson-Boltzmann (PB) equation is then solved in order to 
calculate the electrostatic potential at a number of grid-points. The electrostatic free energy of 
placing a point charge on a grid point is thus calculated, from which the pKa is calculated. This 
method assumes that pKa of a titratable residue depends upon the electrostatic interactions only, 
and all other effects of bond breaking and formation cancels out.
The protonation behavior  of  a  residue  in  protein  may change under  the influence  of 
change in redox state, conformational state or chemical state (e.g. mutation). Such effects are 
often successfully modeled with the help of continuum electrostatic methods. In this chapter, 
applications  and limitations  of  these  methods are  briefly  discussed,  along with a  theoretical 
description.
5.1 pKa calculations : general theory
For any titratable residue at equilibrium,
HA ⇄ H+ + A-    
In this case the acid dissociation constant can be written as,
K a=
[H] [A−]
[HA ]
,
which leads to the well-known Hendersson-Hasselbalch equation,
pH=pK alog 
[salt ]
[acid ]
=pKalog 
[ A−]
[HA ]
 5.1
Probability (P), that the titratable residue is protonated can be written as,
P= [HA ]
[HA ][ A−]
= 1
110pH− pKa
or, pKa=pHlog 
P
1−P
 5.2
Therefore,  in  order  to  calculate  pKa of  a  residue,  its  protonation  probability  P needs  to  be 
evaluated, and the pH at which P=0.5, that would correspond to its pKa [272,273]. This requires a 
titration to be performed, and it is normal in protein titrations to obtain non-sigmoidal curves, 
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which most likely reflect the interactions between multiple titration sites [273].
Probability  P in  eq.  5.2 can  be expressed in  the form of  a  canonical  ensemble formulation 
[274,275],
P=
∑
n=1
n=2N
x
n e−G
n
∑
n=1
n=2N
e−G
n
5.3
where 
Gn=∑
=1
N xn−xo RTln10 pH−pK intr ,∑

N
Wx
n−x
ox
n−x
o 5.4
Here, Gn is the energy of a protonation state n of the protein and there are 2N such protonation 
states. N is the number of titratable residues in the protein, μ (or υ) is the titratable group, and xμn 
takes the values 1 (protonated) or 0 (deprotonated). The variable xμo is the reference uncharged 
state of the group μ, with its values 1 or 0, for acids and bases, respectively. Additionally, pKintr,μ 
is the pKa of a group  μ when all other titratable sites are in their reference protonation states 
(neutral). The Wμυ term is the interaction energy between two charged titratable sites. In order to 
evaluate Gn, the pKintr and site-site interactions (Wμυ) are first calculated. Since the calculation of 
P increases enormously with the increase in the number of titratable groups (N), the Metropolis 
Monte Carlo methods are generally used [275].
The pH independent part, pKintr,μ in eq. 5.4, is first evaluated from the equation,
pK intr ,=
Gintr ,
2.303RT
where Gintr ,=GBornGBack 5.5
ΔΔGBorn is the Born solvation energy associated with the transfer of residue (μ) from the aqueous 
phase  (ϵ=80)  to  the  protein  phase  (lower  dielectric),  whereas  ΔΔGBack corresponds  to  the 
interaction of residue (μ) with all the other background charges present, i.e. solvent molecules in 
the aqueous phase, and other charges in the protein [276]. See Figure 5.1
Figure 5.1 The thermodynamic cycle showing deprotonation of a 
residue in the aqueous phase and in protein. Free energy 
of desolvation (ΔG2 or ΔG3), each consists of 'Born' and 
'Background' contributions. ΔG4 is unknown and ΔG1 is known.
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Each of the contributions in eq. 5.5 are further disaggregated into individual terms,
GBorn=GBorn
A prot
−
−GBorn
AH prot−GBorn
A aq
−
−GBorn
AH aq and
GBack=GBack
A prot
−
−GBack
AH prot−GBack
A aq
−
−GBack
AHaq .
Next, the pH dependent part Wμυ (eq. 5.4) is calculated. It corresponds to the site-site interaction 
energy for when both the sites are charged, and is usually presented in the form of a symmetric 
matrix where diagonal elements are zero [276].
Both pKintr,μ (eq. 5.5) and Wμυ are obtained from the following expression,
Ges=∫V  r r dV 5.6
where  ρ(r) is the charge density and  ϕ(r) is the electrostatic potential, which is calculated by 
solving Poisson-Boltzmann (PB) equation.
5.2 Poisson-Boltzmann equation
The non linearized Poisson-Boltzmann equation can be written as,
∇r ∇ r =−4prot r −4∑
i
z i qno e
− zi qr 
5.7
where ϵ is the space-dependent dielectric constant, ρprot(r) is the charge density, which in the case 
of a protein as solute would correspond to the point charges located on atomic nuclei,  zi is the 
charge of ion i, no is the concentration of ion i in an non-interacting system and q is the protonic 
charge  [277,278].  This  equation  can  be  linearized  by  expanding  the  exponential,  and  by 
assuming low concentration of ions and electro-neutrality. It can thus be written as,
∇r ∇ r =−4prot r 4∑
i
 zi
2q2 no r  5.8
The analytical solutions of eq. 5.8 for complex systems such as proteins do not exist,  hence 
numerical methods are applied. The most commonly used methods are the Finite Difference 
methods, by which electrostatic potential at a number of grid-points is obtained [279,280,281]. 
Mapping techniques are then used to calculate the approximate potential at the location of charge 
in order to obtain the final electrostatic free energy. Moreover, in order to avoid numerical errors 
that  arise  from the  lower  resolution  of  grid,  'focusing'  techniques  are  applied  in  which  the 
increased density of grid points at the site of interest is used such as at the location of titratable  
residue.  As  discussed  in  section  5.1,  when  pKintr,μ and  Wμυ are  obtained,  MC  sampling  is 
performed to calculate the final pKa of a residue (eq. 5.2 and 5.3).
5.3 Strength and weakness of continuum electrostatics method
Continuum electrostatic methods have been successfully used on a variety of enzyme systems 
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[282,283,284,285,286,287,288,289].  Enhancements  of  these  methods  by  including 
conformational  flexibility  also  led  to  improvements  in  the  pKa predictions 
[290,291,292,293,295]. Many different categories of enzymes have also been studied including 
the  difficult  cases  of  redox proteins,  in  which  the  events  that  correspond to  redox  coupled 
protonation have been successfully reproduced [296,297,298]. It has been suggested that even in 
the cases  when variations  in  the electrostatic  potential  are  large,  the  linearized  PB equation 
method can be successfully used to calculate the electrostatic properties [277].
Notwithstanding  the  success,  these  calculations  also  exhibit  limitations  due  to  the 
approximations in the methodology involved [299]. In PB theory it is assumed that the pKa of a 
residue is solely dependent upon electrostatic free-energy, whereas the effects of bond-breaking 
or formation or relaxation are neglected. Such effects may be critical and to disregard them may 
lead to errors in pKa predictions. The treatment of dielectric constant inside the protein is an 
another complicated issue [300]. Although values from 2-5 are commonly used in electrostatic 
calculations, other values that range from 4-20 have also been used and led to impressive results 
[300].
The explicit  treatment  of  water  molecules  in  the  continuum electrostatic  calculations 
have been recommended specially in the cases of metal-ligation [301,302]. However, it has also 
been found to be problematic due to the sensitivity of water-bound hydrogen bonds to the redox 
or conformational changes in the protein [285,301]. Moreover, as there are no straightforward 
ways to treat the dynamic hydrogen bonds in the continuum methods, it is advisable to avoid the  
use of explicit water molecules [303]. 
Many  successful  formulations  have  been  developed  in  order  to  obtain  pKa values 
averaged over an ensemble of structures. However, difficulties in sampling the conformational 
space corresponding to the pH range investigated experimentally or the inclusion of non-biased 
conformational flexibility are currently the bottlenecks [274].
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Chapter 6
Molecular Dynamics Simulations
Molecular  dynamics  (MD)  simulations  allows  the  study  of  time  evolution  of  a  system  of 
particles. As system traces its trajectory in the phase-space, with the help of statistical mechanics 
and  mathematical  tools,  the  microscopic  properties  such  as  positions  and  momenta  can  be 
associated with the observable macroscopic properties such as temperature and pressure. MD 
simulations are very popular in the field of computational biochemistry. Different categories of 
proteins are simulated in a variety of modeled surroundings in order to understand functionally 
important  conformational  changes.  Quantitative  estimates  of  root-mean  square 
deviation/fluctuation,  rate  of  diffusion,  time-resolved  fluorescence  spectroscopy,  side-chain 
motions,  relative  free-energies,  etc. can  also  be  obtained  through  the  equilibrium  MD 
simulations. The range of motions that can be studied using MD simulations is from fast atomic-
level fluctuations, to slow domain movements or folding events. The increase in computational 
power  has  advanced  the  simulation  times  up  to  microseconds  or  milliseconds,  from which 
reasonable  and  more  accurate  statistics  can  be  obtained.  This  chapter  provides  a  brief 
introduction to the MD simulations.
6.1 General Theory
N number of particles with known positions and momenta can be considered as a point on a 
multidimensional  (6N)  phase space.  As time passes the point  moves through this  space and 
assembles  a  trajectory.  If  the  time  allowed  for  propagation  is  long  enough,  then  it  can  be 
assumed that the average of any property over time is equal to its ensemble average. This is 
called the Ergodic hypothesis. Due to this longer MD simulations are often desired in order to 
obtain a reasonable statistics. However, the size of the system such as a biomolecular system, 
always acts as a bottleneck.
MD simulations are built on the platform of classical physics, in which the particles are 
described as spheres with van der Waals radii possessing mass and charge. The bonds, angles, 
dihedral angles between atoms are imitated as springs, added with non-bonded interactions; van 
der Waals and Coulombic interactions. From the initially known position (PDB) and momentum 
(Maxwell-Boltzmann distribution) of each particle, the potential energy of the system can be 
calculated, and the forces on all atoms are evaluated. Due to the coupled movement of particles 
and  larger  number  of  degrees  of  freedom,  the  equations  of  motion  are  solved  numerically. 
Newton's equations of motion characteristically conserve energy and momentum and are fully 
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reversible. Consequently, MD simulations also conserve energy and are in principle reversible.
The commonly used form of the potential energy function is,
V r =∑ K bb−bo2∑ K −o2∑ K [1cos n−]∑ ij[ Aijrij 
12
−Bijr ij 
6
]∑ qi q ir ij
where V(r) is the total potential energy. The sums in above equation (eq. 6.1) cover all possible 
bonds, angles, dihedral angles and atom-pairs. The first three summation terms correspond to the 
bonded interactions,  whereas  the  last  two represent  the  non-bonded  interactions.  Both  bond 
(first) and angle (second) terms are harmonic approximations, whereas the third dihedral angle 
term is  usually represented in  the form of a periodic function.  Kb,  Kθ,  and  Kϕ are the force 
constants  that  are  defined for each type of  bond, angle and dihedral,  respectively.  They are 
usually determined by the high-level quantum chemical calculations on small model systems or 
by spectroscopy [304,305]. The terms bo and θo are the equilibrium values of bonds and angles, 
respectively, and are also determined through experiments or computational procedures [304]. In 
the equation 6.1, n is the multiplicity and δ is the phase, which is usually 0˚ or 180˚, however, 
other  values  have  also  been suggested.  Moreover,  ϵ is  the  dielectric  constant  and  rij is  the 
distance between the atoms i and j. Aij and Bij are the coefficients to model the 12-6 (repulsive-
attractive)  Lennard-Jones  (LJ)  potential,  and  qi,  qj represents  the  partial  charges  on  atoms 
obtained  through  quantum  chemical  calculations  or  other  procedures  [304,305].  From  the 
potential energy, the forces on atoms are calculated by the relationship,
Fi=−∇V r i
The potential energy equation, its derivatives, and above listed parameters such as force 
constants, equilibrium values,  etc., are collectively referred to as 'forcefield'. Various standard 
forcefields are popular in the field of biomolecular computations such as CHARMM, AMBER 
or  OPLS  [306,307,308,309].  Each  forcefield  has  its  own  methodology  to  determine  the 
parameters, and it is usually not advisable to mix the parameters from two different forcefields. 
In order to describe and simulate the protein systems, forcefield and parameter sets are compiled 
as efficient programs or software, which can be run on multiple processors. NAMD is one such 
program that is capable of achieving high scalability on multiple processors [310]. 
Since partial charges used in potential energy equation (6.1) are non-variable, most of the 
current development in this field is concentrated on the inclusion of polarization effects [311]. 
Recent  studies  have  indeed  shown  improvements  with  the  inclusion  of  fluctuating  charges 
[311,312,313].
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6.1.1 Integration schemes
In order to achieve both speed and accuracy in a simulation, efficient integration schemes are 
suitably coded in the MD simulation packages. A brief overview of the most popular integration 
schemes is given in this section.
In general, new positions and velocities of all atoms at time (t + δt) can be obtained from 
the Euler's method, in which both position and velocity terms are expanded in Taylor series,
r t t =r t r ' t   t
1!
r ' ' t  t 
2
2 !
O t 3⇒ r t t =r t v t   t
1!

F
m
 t 2
2 !
O t 3
and v tt =v t 
F
m
 t 
1 !
O  t 2 6.2 and 6.3
However,  such  basic  integration  schemes  are  known  to  violate  the  characteristic  time-
reversibility, and they suffer with larger errors in the order of (O(δt)3). Therefore, more stable 
algorithms have been proposed, such as Verlet integration [314]. In this scheme, a second Taylor 
expansion is used in addition to the one already described in Euler's method (eq. 6.2 and 6.3),
r t− t =r t −v t   t
1 !

F
m
t 2
2!
−O  t 3 6.4
Addition of the two expansions 6.2 and 6.4 yields,
r t t =2r t −r t−t 
F
m
 t 2
2!
O  t 4 6.5
This new formulation clearly provides an improvement due to the smaller magnitude of error in 
position (O(δt)4), whereas velocities still retain error, due to the (O(δt)2) or (O(δt)) term,
v t = r t t −r t−t 
2 t
O  t 2
or v tt =
r t t −r t 
 t
O t  6.6
In order to limit errors in the velocity calculation of the Verlet integrator, another scheme has 
been suggested, where,
v tt =v t at a t t 
2
 t  6.7
This formulation is called Velocity Verlet [304], and it helps in achieving higher accuracy with 
only minor increase in the computational cost [304]. One of the popular MD package NAMD 
uses  the  Velocity  Verlet  integrator  by  default,  whereas  CHARMM  utilizes  the  Leap-Frog 
Algorithm, which has a high similarity with the former integration algorithm.
Irrespective  of  the  integration  schemes  described  above,  the  limited  accuracy  of 
computer's floating point operations and the stochastic nature of commonly used non-Newtonian 
equations  such as, Langevin dynamics or Brownian dynamics, always causes a simulation to 
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diverge  from  its  original  trajectory  [315].  This  phenomenon  is  explained  in  terms  of  the 
Lyuapunov instability, for which any two simulations that start from the same point in the phase 
space  will  diverge  over  a  period  of  time.  This  may  not  be  a  limitation  in  cases  when  a 
sufficiently large phase-space needs to be explored. However, the existence of some degree of 
synchronization  in  trajectories  due  to  the  'seed'  problems  of  computers  may  lead  to  less 
divergence among trajectories than desired [316].
In  order  to  increase  the  length  of  simulation  times,  numerous  schemes  have  been 
developed. In one of the most commonly used methods, the fastest motions of the lightest atoms 
(hydrogen atoms) are ignored, and a time-step of 1 or 2 fs is easily used [317,318]. Furthermore, 
when simulations are performed using Coarse-grained models [319], much larger time-steps can 
be used, even though such simulations do not provide details on the atomic-level. Other kinds of 
simulation approaches are also utilized in order to explore the large conformational space. These 
include  simulated  annealing,  replica-exchange MD,  torsion-angle dynamics,  etc. In  addition, 
these  approaches  can  also  allow  in  overcoming  energy-barriers  which  are  inaccessible  to 
equilibrium MD simulations.
6.2 Statistical ensembles and thermodynamics
MD simulations  are  performed by mimicking the experimental  conditions.  The macroscopic 
details of the environment are conveniently associated with the microscopic details that have 
been  obtained  from  the  MD  simulations  through  the  theory  of  statistical  mechanics  and 
thermodynamic ensembles [320].
The NVE or microcanonical ensemble corresponds to a constant number of particles (N), 
volume  (V)  and  energy  (E),  and  is  the  most  basic  kind  of  ensemble  in  statistical 
thermodynamics. MD simulations by solving Newton's equations of motion conserve energy (E) 
and momentum by default,  thus  reproducing the NVE ensemble.  Moreover,  absence  of  any 
external force in the simulation renders the total energy value to remain constant throughout the 
simulation,  though  an  initial  increase  in  kinetic  energy  and  decrease  in  potential  energy  is 
unavoidable as the system relaxes. Each snapshot in the simulation corresponds to a microstate 
with  fixed  N,  V and  E.  The  number  of  such microstates,  corresponding to  the  energy E at 
equilibrium, is given by,
N ,V , E=∑
i
H ip ,q−E where ={0, H i≠E1, H i=E 6.8
where Ω is the microcanonical partition function, Hi is the Hamiltonian and vectors p and 
q define the momenta and positions of all particles in the system. Summation in eq. 6.8 covers 
all microstates i. The partition function Ω is an important quantity in statistical thermodynamics 
42
from which all other thermodynamic functions such as entropy can be calculated,
S=kB ln  . 6.9
However, in practice it is nearly impossible to calculate Ω due to the enormous size of the 
phase  space. The  most  important  consequence  of  this  ensemble  formulation  is  that  all 
microstates are equally likely, therefore probability (Pi) of finding the system in any one of the 
microstate is  1/Ω. Moreover, from the probability and the assumption that the  time average is 
equal to the ensemble average, the average of any property A can be calculated as,
〈 A 〉=∑
i
A i P i
6.10
NVT (canonical) ensemble on the other hand corresponds to the constant temperature (T) 
instead  of  energy  (E),  which  is  achieved  by  connecting  the  system to  an  external  thermal 
reservoir. The mathematical description of this ensemble forms the basis of statistical mechanics 
where the formulation of partition function (Q) turns out to be different from above,
Q=∑
i
e− E i 6.11
Here i covers all the microstates, and Ei is the energy of the ith microstate. Similar as above, the 
thermodynamic average of property A can be written as,
〈 A 〉=
∑
i
A ie
−Ei
∑
i
e−E i
6.12
There are other ensembles such as the isothermal-isobaric (NPT) or grand canonical ensemble 
that are similar in formulation to these aforementioned ensembles [320]. Depending upon the 
type  of  simulation,  the  appropriate  ensemble  theory  can  be  used  to  calculate  the  average 
properties, energetics and other thermodynamic functions.
6.3 Molecular Dynamics: Methods for constant temperature and pressure
6.3.1 Constant temperature
Alternative methods have been developed in order to keep the temperature constant during the 
MD simulations.  The earliest  methods relied upon the simpler velocity re-scaling techniques 
[304].  Since,  average  kinetic  energy  is  directly  related  to  the  temperature  through  ‹KE› = 
3/2NkBT, scaling factors such as T o /T were proposed, in which To is the desired temperature 
and T is the temperature at time t. However, these methods and successive refinements [321] did 
not reproduce the desired canonical distributions. Therefore, more advanced temperature control 
methods, such as the Nosé-Hoover thermostat were developed. In the Nosé-Hoover thermostat 
method additional terms are integrated into the canonical Hamiltonian and equations of motion 
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are solved [322,323]. This method successfully led to the desired canonical distributions, and 
since then it has been used in many MD simulation studies.
Currently another method of choice is Langevin dynamics, which introduces frictional 
and random forces into the Newton's  equation of motion,  thereby mimicking solvent  effects 
[324]. It has successfully been used to maintain constant temperatures in MD simulations, and 
has produced the required ensemble distributions [324]. Langevin equations are given by,
Fi=−∇V r i−mi r
.
W it  6.13
where γ is the friction coefficient and W is the random force. Damping or friction coefficient γ  
describes the amount of friction in the system. Larger values would cause a high friction and that 
would result in a slower diffusion, such as in Brownian dynamics, whereas too small a value 
may result in larger temperature fluctuations.
6.3.2 Constant Pressure
Constant  pressure  and volume effects  are  simulated  by  placing  the  macromolecule  inside  a 
simulation  cell  of  variable  size  and  geometry.  Depending  upon  the  requirements  either  the 
pressure  fluctuates  (NVT  ensemble)  or  the  volume  (NPT  ensemble).  Methods  have  been 
developed by which the volume of the simulation cell is scaled by a factor at each time step in 
order to keep the pressure constant [321]. Methods such as the Nosé-Hoover Langevin Piston 
pressure control [327], along with other methods [325,326], allows the generation of required 
NPT ensemble, and are used commonly in the MD simulations.
6.4 MD simulations on biomolecules
Current research in the field of MD simulations is aimed at modeling the biological systems as 
realistic as possible. In the case of simulations on membrane proteins, an atomic-level membrane 
model surrounding the protein can be constructed [328,329], which helps to avoid the surface 
effects at the protein surface. The hydrophilic region is also modeled by the inclusion of explicit 
water molecules and ions [328,329].  However,  micro-  or nano-second length simulations on 
such massive systems are prohibitive, especially when many redox or chemical states are to be 
simulated.  Therefore,  such simulations  on membrane proteins  can be performed in vacuum, 
specially in those cases in which the region of interest lies deep inside the protein surface, and 
where surface effects are small.
MD  simulations  on  proteins  are  also  performed  by  employing  Periodic  Boundary 
Conditions (PBC). In this case a replica of the central simulation cell is extended in all three 
spatial dimensions, such that atoms at the surface of the cell do not encounter a vacuum. This 
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reduces the surface effects and provides a more realistic description of the bulk properties [304]. 
The dynamics of  the central  cell  is  replicated in  all  the other  cells,  whereas  the number of 
particles in the central cell can be kept constant by allowing the passage of particles through the 
boundaries [304]. 
Due  to  the  large  computational  cost  associated  with  the  calculation  of  non-bonded 
interactions,  MD  simulations  are  often  performed  using  the  smoothing  cut-off  procedures. 
However, non-bonded electrostatic interactions are long-ranged and despite the shielding effects 
from the solvent and parts of the protein, truncation by smoothing procedures sometimes yield 
incorrect results, especially in cases of charged complexes such as DNA [330]. Therefore, Ewald 
summation techniques (or Particle-Mesh Ewald for periodic systems) are used to treat the long-
range electrostatic effects, and are popularly used in the MD simulations on proteins or nucleic-
acids [331,304].
Simulations of longer time scales are desired in order to obtain reasonable quantitative 
results.  This could be achieved by increasing the time-step of integration [332],  though that 
occurs at the cost of accuracy. Therefore, simulation techniques such as constrained simulations 
have been developed, in which certain degrees of freedom are constrained such as bond length 
and angles, which helps in increasing the time-step of integration. One such prominently used 
algorithm is SHAKE [317]. In this algorithm, bond lengths associated with the hydrogen atoms 
are often constrained, which leads to an increase in the time-step from 1 fs to 2 fs and without 
the loss of accuracy.
The MD simulations on proteins such as those which perform redox chemistry require 
partial-charges and parameters for the metallic co-factors, and those are often not available in the 
standard forcefields, due to the massive task of parameter development and refinement. Multiple 
methods exist to generate the partial charges for such systems, and enable their successful use in 
the  simulations  [333,334,335,336,337].  Optimization  of  non-bonded  parameters  is  also  a 
mammoth  task  similar  to  the  partial  charge  development  [305].  However,  non-bonded  LJ-
parameters (ϵij and Rij) of hetero-diatomics are often obtained from the available LJ parameters 
of individual atoms [304,305,306] by using combination rules like,
ij=i  j and Rij=
RiR j
2
This  helps  in  avoiding technical  and methodological  challenges  that  occur  in  the  parameter 
development with little loss in accuracy. Nevertheless, the forcefield parameterization of metal 
centers present in an enzyme is not a straightforward automated task and requires optimization 
of several parameters at the same time [338].
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Chapter 7
Aims and methods
7.1 Aims
The following were the specific objectives of the work presented in the thesis:
A) To identify the conserved amino acid residues and proton transfer pathways in the cbb3-
type oxidases.
B) To model  the differential  local  effects  and their  importance  in  oxygen reduction  and 
proton pumping mechanism of A- and C-type oxidases.
C) pKa calculations to identify the proton-loading sites in A- and C-type oxidases.
D) To identify the functional groups involved in the redox coupled proton transfer in C-type 
oxidases.
7.2 Methods
7.2.1 Multiple sequence alignments and homology modeling
In studies  (publications)  I  and II,  multiple  sequence alignments that  comprised the catalytic 
subunits from A-, B- and C- type oxidases were generated (Fig. 3.1), and used to construct the 
homology model of C-type oxidase from  R. sphaeroides.  Due to  the low pairwise sequence 
identity between the sequences (~20%), there was a high probability of generating incorrect 
alignments and incorrect homology models. Therefore, in order to achieve as high an accuracy 
as possible, a structural alignment was first generated in which the catalytic subunits of A- and 
B-type oxidases were aligned by superimposing the helical segments by using VMD/STRIDE 
[339,340]. Subsequently, enzyme sequences were aligned to the structural alignment, which was 
marked with the secondary structure definitions based on the structure of A-type oxidase from B. 
taurus [69]. The secondary structure definitions corresponding to the latter structure were used, 
since it was the highest resolution crystal structure available at that point of time. The sequences 
of A- and B-type oxidases were aligned to the sequence-structure alignment in small subsets 
using the  sequence-to-profile  methodology. The presence of conserved histidine residues over 
the span of sequence helped in achieving reasonable global alignment. Furthermore, the presence 
of a secondary structure profile did not allow insertions in the conserved helical segments, and 
also restrained the length of the TM regions.
C-type  oxidases,  though  deviant  from  other  members  of  HCOs,  form  a  conserved 
subclass among themselves. Sequences of C-type oxidases from many different organisms were 
first aligned, and then added to the above alignment by profile-to-profile methodology. Multiple 
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trials were performed in order to assess the variability of the non-conserved regions. Available 
structural data on the A- and B-type oxidases were also used in order to manually adjust the 
alignments in the regions of low sequence conservancy. Additionally, sequence alignments of b-
subunit of NORs were also found instrumental due to the local structural similarity between the 
catalytic  subunits  of  NORs  and  C-type  oxidases.  All  alignments  were  performed  using  the 
CLUSTAL program [180]. 
Homology modeling was performed with the program MODELER (version 7v7) [194]. 
From the alignment obtained above, the two template sequences (catalytic subunits of A-type 
oxidase from B. taurus and B-type oxidase from T. thermophilus) were extracted, along with the 
target  sequence  of  C-type  oxidase  from  R.  sphaeroides.  The  use  of  two template  structures 
allowed MODELER to select the better of the two along the sequence length, but at a cost of 
larger violations in the optimization schedule. However, it was later realized that most violations 
occurred in the loop regions where template and target sequences were the most divergent. The 
topologies and parameters of standard amino acid residues and metal centers were obtained from 
the standard forcefield or from the 'in-house' developed topologies/parameters [341]. No changes 
were observed in the final models upon change in the redox states of the metal centers. Based on 
the analysis of template structures, special restraints available in MODELER were used to model 
the interactions between protein and heme propionates. Out of total 50 models generated in each 
trial, five with the lowest value of MODELER objective function (section 3.3.1.1) were selected 
for further analysis. They were subjected to stereochemical checks using PROCHECK [209] and 
Molprobity  [210].  Though  MODELER's  inherent  optimization  method  involves  an  energy 
minimization step, separate minimizations were also performed using NAMD [310]. The energy 
minimization causes a minimal drift in the structure, and removes steric clashes and strains from 
the system, whereas molecular dynamics may degrade the models far from their native state 
[342,343,344].
7.2.2 Continuum electrostatic calculations
In  studies  IV  and  VI,  continuum  electrostatic  calculations  were  performed  on  the  crystal 
structures and also on the snapshot structures that were obtained from the MD simulations. In the 
latter case, in which conformational sampling was achieved through MD simulations, it  was 
found critically important to select a representative set of structures. This was due to the larger  
fluctuations  in  pKa values,  even  when  the  structural  variations  were  non-local.  Previously 
methods  have  been  described  by  which  individual  conformers  can  be  weighted  using  the 
forcefield  based  non-electrostatic  energies.  However,  such  approaches  were  found  to  be 
unsuccessful in the current case due to the biasing of one single conformer over all the others,  
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even when the difference between non-electrostatic energies of different conformers was small 
(unpublished information). 
Continuum electrostatic calculations presented in publications IV and VI correspond to 
the enzymes from A- and C-type subfamilies, respectively. In publication IV, a representative set 
of structures were selected from the simulation trajectories that correspond to the two different 
conformations  of  A-propionate  of  heme  a3,  i.e. 'open'  and 'closed'.  The  'open'  conformation 
corresponds to the case when the hydrogen bond between the A-propionate and AI:Asp364 is 
broken,  whereas  in  'closed'  it  remains  intact.  Continuum electrostatic  calculations  were then 
performed for the different  redox states.  The  pKa values were averaged over  the number of 
selected snapshots. In addition, auxiliary calculations were performed by mutating AI:Asp364 to 
an asparagine, thereby mimicking the propionate-protein interaction in the  cbb3-oxidases. The 
titration behavior of the whole protein was also analyzed in different redox states.
In study VI, pKa calculations were performed on the crystal structure of cbb3-oxidase and 
on the snapshots obtained from a short 250 ps MD simulation. The titration profile of the whole 
two subunit enzyme, and also the pKa values of a larger set of active-site residues were obtained 
in different redox states.
Due to the dynamic nature of the hydrogen bonding patterns, explicit water molecules 
were  not  modeled  in  either  of  the  above  calculations,  whereas  solvent  cavities  and 
protein/membrane dielectric continua were modeled with  ϵ=80 and 4, respectively. Water/OH- 
ligands of the metal centers were treated explicitly when required. Software MEAD [276] was 
used  to  calculate  the  ΔΔGBorn, ΔΔGBack and  site-site  interaction  energies  (Wij),  whereas 
KARLSBERG [275] was used to perform the Monte-Carlo sampling in order to obtain the final 
pKas. It has been observed before [284], and also confirmed in this work, that the variation in the 
pKint values due to the structural variations is less, relative to the final pKa values. In a number of 
cases it was also observed that  ΔΔGBorn  and ΔΔGBack  nearly canceled each other, and final  pKa 
were  perturbed  due  to  the  Wij terms  only.  Similar  observations  have  also  been  reported 
previously [276].
In the calculations, charges of amino acid residues were obtained from the forcefield 
CHARMM [307], whereas charges of metal centers in different redox states were calculated 
using high-level DFT calculations, as described in the next section.
7.2.3 Density functional theory calculations
High structural similarity in the active-site region of all HCOs allowed DFT calculations to be 
performed  on  the  cluster  models  constructed  from  the  homology  model  of  cbb3-oxidase 
(publications III and V). In contrast, in the case of A-type oxidase, cluster models were built 
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from the available  crystal  structures (publications  III  and V).  Additionally,  DFT calculations 
were performed on the models built from the recently solved crystal structure of cbb3-oxidase, as 
discussed in the publication VI. 
DFT calculations were performed in different redox states, and in the absence or presence 
of  non-proteinaceous  metal-ligands  such  as  OH- or  H2O.  Optimized  geometries,  electronic 
energies, spin-densities, redox potentials and partial charges were obtained from the calculations. 
In order to prevent any larger deviation from the initial structure, the termini atoms such as Cα or 
Cβ were  kept  fixed  during  the  geometry  optimizations.  The  GGA density  functional  BP86 
[242,244] was used in all the geometry optimizations, with SVP basis set on all C, N, H and O 
atoms, whereas metals such as Fe and Cu were treated with the TZVP basis set [345,346]. The 
default convergence criteria of the program TURBMOLE [252] were used during the geometry 
optimizations, which were performed in the gas-phase. The Multipole Accelerated Resolution of 
Identity-J (MARI-J) algorithm available in TURBOMOLE was used to speed up the calculations 
[347]. Figure 7.1 shows the optimized geometries of metal centers present in the cbb3-oxidase.
Figure 7.1 DFT optimized geometries of the A) CuB, B) heme b3, C) heme b, and D) heme c metal centres present in 
the  cbb3-oxidase from  P. stutzeri. The geometry optimizations were performed with the GGA density functional 
BP86, with SVP basis set on C, N, H, O and Ca atoms, and TZVP basis set on Fe and Cu atoms. Figure is published  
after permission from the publisher.
As higher accuracy was sought for the evaluation of properties such as relative energies, 
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spin densities, redox potentials and partial charges, hybrid density functional B3LYP [249] was 
used along with the TZVP basis set on all atoms (publications III, V, VI). The protein dielectric 
was modelled  as  a  continuum with  ϵ=4 using the COSMO methodology [253]  available  in 
TURBOMOLE.  Unrestricted  (open-shell)  DFT  calculations  sometimes  suffer  from  spin-
contamination, in which the expectation value of the total spin-squared operator  <S2> differs 
from  the  actual  S(S+1) [348,349].  In  the  calculations  performed  here,  the  extent  of  this 
contamination was found to be minimal. Moreover, the LUMO-HOMO gap was also found to be 
positive in all the calculations reported here. These analyses suggest that obtained results can be 
considered to be reliable. 
The partial charges of all the atoms of the active-site models were obtained using the 
Merz-Kollman scheme [333]  available  in  TURBMOLE.  According to  this  methodology,  the 
quantum chemical electrostatic potential is made to fit the potential due to the point charges 
centered on atomic nuclei. In study VI, these partial charges were used for the pKa calculations 
and MD simulations.
7.2.4 Molecular dynamics simulations
In  study II  molecular  dynamics  simulations  were  performed on the  water-loaded homology 
model, whereas in study VI simulations were performed on the recently solved crystal structure 
of cbb3-oxidase. All simulations were performed by using the program NAMD [310]. The water 
molecules were predicted in protein cavities based on the interaction energy approaches [350]. 
Different energy cut-offs of water prediction were applied and tested in study VI. All simulations 
were performed in vacuum, and based on the root mean square deviation (rmsd) vs time plot, it 
was observed that the system remained stable over nanosecond timescales (Figure 7.2).
In the simulations presented in study VI, the temperature was kept constant at 310 K by 
using the Langevin dynamics method available in NAMD with damping coefficient = 0.1 ps -1. 
Time step of 1 fs was used in all the simulations, and data were saved every 100 steps. The non-
bonded cut-off of 20 Å and smoothing criteria of 18 Å were applied.  The standard forcefield 
parameters  along  with  the  'in-house'  developed  parameters  were  used  for  the  protein-metal 
systems, whereas charges were obtained from the DFT calculations as described earlier (section 
7.2.3). Standard protonation states of all amino acid residues were considered, except the ones 
which showed deviated pKa values. Multiple simulations of 5 ns each, after 1 ns equilibration, 
were  performed  in  different  redox  states.  This  most  likely  helped  in  exploring  larger 
conformational space, and also allowed the water molecules to attain a relaxed state inside the 
protein interior.
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Figure  7.2  rmsd  vs time  plot,  based  on  a  1  ns  equilibration  and  5  ns  production  run  in  OROO redox  state 
(publication VI).  Cα atoms were used to align and superimpose the structures on the initial frame.
In study II, short MD simulations of 450 ps were performed in order to identify the stable 
arrangement of side-chain of cross-linked tyrosine in the water-loaded homology models. Due to 
the  likelihood  of  degradation  in  quality  of  homology  models  during  the  MD  simulation, 
harmonic constraints were put on all the Cα atoms.
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Chapter 8
Results and discussion
8.1 Homology model of cbb3-oxidase and its comparison with the crystal structure
The superposition of the helical segments of the homology model of cbb3-oxidase on the crystal 
structure yields 2.35 Å rmsd for the Cα atoms (Figure 8.1A and 8.1B). It is observed that the 
region from helix VI to VIII, and some of the interactions between protein and heme propionates 
are correctly predicted by the homology models. The crucial active-site tyrosine (section 2.5.3), 
which is fully conserved in the A- and B-type oxidases in helix VI, is located in the helix VII of 
cbb3-oxidases.  The  homology  models  provided  the  first  insight  as  to  where  the  tyrosine 
CI:Tyr251 in helix VII can possibly make a covalent bond with the histidine ligand (CI:His207) 
of CuB (publications I and II). Figure 8.1C shows the side-chain of tyrosine in proximity of the 
histidine ligand and also nearly matching the crystal structure conformation. This prediction is 
confirmed by the site-directed mutagenesis, mass-spectrometry and recent crystal structure data 
[43,156,157].  Moreover,  the  side-chain  dihedral  χ2,  inter-planar  angle  between histidine  and 
tyrosine, and the improper torsion (Cε1His207-Cε1Tyr251-Nε2His207-Cδ2His207) in the energy minimized 
crystal structure are 137°, -14° and 176°, respectively. These values closely match the predicted 
values in the refined homology model (publication II).
In the region from helix VI to VIII the local similarity between the template sequence 
(1EHK.pdb) and target sequence is relatively high. Hence, a putative proton channel is predicted 
in the C-type oxidases in the region where a functional proton channel exists in both the A- and 
B-type oxidases (publication I). The presence of this channel in C-type oxidases is confirmed 
with  the  site-directed  mutagenesis  studies  and  recent  X-ray  structure  [43,156].  Figure  8.1C 
shows the correctly predicted backbone and sidechains of amino acid residues involved in the 
proton channel.
However, due to errors in the alignment, particularly in the regions from helix III to V, 
and  loop  between  helices  XI  and  XII,  some  backbone  and  side-chain  atoms  are  modelled 
incorrectly (Figure 8.1A and 8.1D). This is either due to the low sequence conservancy between 
the template and target sequences or due to the incorrect modelling procedure applied. 
Multiple sequence alignment in the regions of low sequence similarity tend to depend 
upon the order in which sequences are added and aligned. Structural alignments, multiple trials 
and manual intervention play important roles in assigning the variable parts more accurately. In 
the multiple sequence alignment obtained in study I after several trials, it is observed that besides 
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the fully conserved metal-ligating histidines there are only few other highly conserved residues 
in the whole HCO superfamily. Two of these are; CI:Pro282 in helix VIII, and CI:Gly324 in 
helix IX. When compared with the crystal structure and structural alignment [43], both these 
residues are correctly predicted in the alignments and homology models. Proline is located in the 
region of  the  K-channel  of  A-type oxidases,  where  it  most  likely  provides  the  helix  with a 
functional flexibility [74,351]. On the other hand, glycine is located near the high-spin heme, 
and due  to  the  absence  of  side-chain  it  packs  closely  to  the  heme and  its  histidine  ligand. 
Glycines are  known to be located in  the regions  where tight  packing is  required [352],  and 
indeed a bulky residue at such a position affects the activity of the oxidase [353]. Additionally, 
many of the glycines (CI:Gly391 and CI:Gly403), which were used as a yardstick during the 
alignment generation are also modelled correctly.
Figure 8.1 Local and global comparisons between the homology model of the catalytic subunit of cbb3-oxidase from 
R. sphaeroides, and the same subunit from the crystal structure of P. stutzeri enzyme. Side (A) and top (B) view of 
the  superposed  structures;  pink,  model;  ice  blue,  crystal  structure.  Closely  matching  side-chain  conformations 
between the model (green) and the crystal structure (yellow), in the region of the putative proton-channel (C), and 
above heme propionates (D). All amino acid numbering corresponds to the subunit N of the cbb3-oxidase from P. 
stutzeri, except the incorrectly modelled Arg471(M). Hemes are shown in licorice representations (cyan for x-ray 
structure, and orange for the model). 
The  section  from  helix  III  to  V  is  variant  in  all  the  three  subfamilies  of  HCOs 
(publication I). In the A- and B-type oxidases, amino acid residues from loop III-IV participate  
in charged interactions with the heme propionates, and are important in proton pumping. Based 
on  local  similarities  in  the  template  and  target  sequences,  such  interactions  were  modelled 
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explicitly in studies I and II (see also section 7.2.1), and interestingly, part of the predictions 
turned-out to be correct, namely that:  a) a highly conserved arginine (CI:Arg57) from helix II 
interacts with the low-spin heme propionates, and b) a conserved tyrosine from the loop III-IV 
(CI:Tyr123) hydrogen bonds to the D-propionate of the high-spin heme [43] (Figure 8.1D). In 
contrast, the explicitly modelled interactions between the D-propionate of high-spin heme and 
the  residues  from  loop  XI-XII  are  found  to  be  incorrect.  Instead  of  a  modelled  arginine 
(R471(M) in  Fig.  8.1D),  a  Ca+2 ion  neutralizes  the  negative  charge  of  the  propionate  [43]. 
Nevertheless, part success in the correct identification of heme propionate partners highlights the 
role of manual intervention in homology modelling.
In the first models the role of a highly conserved glutamate in helix IX (CI:Glu323) was 
unclear. However, a putative proton channel was suggested based on its location and mutational 
data  in  study I.  Recent  biochemical  studies  in  conjunction with  redox titrations  identified a 
hydrogen bond between the glutamate and the histidine ligand of high-spin heme [159], which is 
also  confirmed  by  the  recent  crystal  structure  [43].  This  experimental  input  led  to  the 
improvement in models, and another highly conserved interaction between the glutamate and the 
tryptophan  (CI:Trp341)  is  predicted  in  study  III.  This  prediction  is  also  supported  by  the 
confirmation from the recent structure [43]. As discussed in a later section, pKa calculations and 
MD simulations indeed suggest a role of this glutamate in proton transfer (publication VI).
Due to the difficulty in aligning one of the two conserved tryptophans in helix VI of cbb3-
oxidases  to  the  only  conserved  tryptophan  in  the  A-type  oxidases,  two  different  models 
'continuous' and 'gapped' were constructed in studies I and II. Comparison with the recent crystal 
structure and the structural alignment presented in the reference [43] reveals that one of the two 
predicted models is correct, and manual insertion of a gap in the region led to incorrect results. 
The tryptophan (AI:Trp236) forms a stacking interaction with the histidine ligand of CuB, and its 
mutation to other residues sharply decreases the catalytic activity of the oxidase [354]. A similar 
result can also be expected in the cbb3-oxidases for analogous tryptophan CI:Trp203.
8.2 Quantum chemical modelling of the active-site
The  overall  arrangement  of  the  active-site  is  similar  in  both  A-  and  C-type  oxidases. 
Nonetheless,  there  are  local  structural  differences,  which  might  be  important  in  the  oxygen 
reduction and proton pumping mechanisms. The DFT calculations were performed on the cluster 
models of both the oxidases in order to identify the differences in energies and structure of the 
intermediate states. In the case of cbb3-oxidase, a model system that comprised of BNC region 
was  constructed  from  the  homology  model,  whereas  for  the  aa3-oxidase,  available  crystal 
structure was used. The models are relatively large and comprise ca. 200 atoms. 
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DFT calculations showed large differences in the spin-density distribution on heme and 
its histidine ligand in the two model systems (A and C) in the oxidized state (Figure 8.2). 
Figure  8.2  Spin  densities  in  small  model  systems. 
Left (oxidized), right (reduced). a), b) corresponds to 
the active site of A-type oxidases, whereas  c), d) to 
the C-type oxidases. e), f) systems are variants of c),  
d) in  which  glutamate  is  in-silico mutated  to  a 
glutamine. Isocontour plots at the value of 0.001 e/Å3 
are shown with colours blue and red representing the 
excess α and β densities, respectively.
The differences in spin density on histidine in 
the oxidized case are clearly visible in a), c) systems, 
whereas  e) shows spin distribution more similar to 
a).  Figure  is  published  after  permission  from  the 
publisher, and is from publication III.
These differences in spin-density can be associated with the rhombic EPR spectrum that 
is obtained in the C-type oxidases as compared to the axial spectrum of A-type oxidases [159]. 
Preliminary calculations also suggest differences in the EPR  g-tensors and zero-field splitting 
parameters  (E and  D)  for  the  two  model  systems  (unpublished  data).  Furthermore,  upon 
reduction of heme, spin distributions in both the model systems are found to be similar as shown 
in Figure 8.2b and 8.2d. The most likely reason for the observed differences is the presence of 
the glutamate (CI:Glu323) in the proximal cavity of  heme b3, which hydrogen bonds with the 
histidine ligand of the latter (Fig. 8.2c and 8.2d). This unique interaction in the  cbb3-oxidase 
modulates  the  geometrical  and  also  the  electronic  structure  of  the  BNC.  The  proximal  site 
architecture  also  resembles  that  is  found  in  the  peroxidases,  where  an  analogous  aspartate 
modulates the electronic and geometrical characteristics of the system [160]. Additionally, in 
study III, a redox dependent proton movement is observed in both small and large cluster model 
systems of cbb3-oxidase. The proton shared between the histidine and glutamate is found closer 
to the glutamate in  the oxidized state,  whereas in the reduced state  it  is  more closer  to the 
histidine  (Figure  8.2c  and  8.2d).  The  preference  of  proton  on  one  of  the  residues  is  also 
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supported by the energetic and frontier orbital analysis (publication III). However, in peroxidase 
enzymes in which an analogous system (Fe-His-Asp) exists, the position of the shared proton 
has been found to be closer to the histidine ligand based on the hybrid QM/MM calculations 
[355].
The  possible  effect  of  hydrogen  bonding  between  histidine  and  glutamate  on  the 
energetics of oxygen reduction reaction was also studied. Models of A- and C-type oxidases 
were constructed in a similar manner as described above, and the reaction sequence A→IP→PM 
was  studied.  It  is  observed  based  on  the  analysis  of  electronic  energies  that  the  peroxy 
intermediate (IP) is more stable in the cbb3-oxidases compared to the aa3-oxidases (publication 
V). This finding would lead to a higher occupancy of intermediate IP ([IP]) and a higher rate of 
PM formation (d[PM]/dt). Consequently, this would also lower the Michaelis-Menten constant KM 
in the case of cbb3-oxidases [356]. Interestingly, it is well-known that Michaelis-Menten constant 
KM in  cbb3-oxidases  is low in the nM range, and they possess a relatively higher affinity for 
oxygen as compared to the other HCO superfamily members. The two most likely reasons for 
the stabilization of  IP intermediate in  cbb3-oxidase  are,  a) the presence of negatively charged 
glutamate in the proximal site of heme b3, and b) different sidechain orientation of cross-linked 
tyrosine (CI:Tyr251). Both these characteristic features of C-type oxidases also classify them as 
being different from the A- or B-type oxidases [43]. Moreover, as observed in study V,  ca. 10 
kcal/mol electrostatic stabilization of  IP intermediate in  cbb3-oxidases is most likely caused by 
these distinct structural features. 
The electronic energies of other intermediate states such as R, A and PM are found to be 
similar  in  both  the  oxidases.  The  approximate  20  kcal/mol  exergonicity  from  R →  PM if 
combined with the 10 kcal/mol entropic contribution [357] would yield 10 kcal/mol overall 
exergonicity, which is in harmony with the previous similar DFT studies made on the A-type 
oxidases [115,128,129]. 
In general it is difficult to judge the formal oxidation states of metal centers based on the 
Merz-Kollman (MK) charges, as charges tend to migrate to metal-ligands or other locations. The 
same holds true for other functional groups, however, in the current calculations MK charge 
analysis of the cross-linked tyrosine shows that it has a neutral charge in the PM state (0.17 and 
0.02 in  A and C models,  respectively),  which implies  that it  most  probably forms a neutral 
radical and provides the fourth electron during the oxygen splitting reaction (publication V). 
Figure  8.3  also  confirms  this  where  the  unpaired  electron  distribution  on  the  cross-linked 
tyrosine in the PM intermediate is shown. 
Figure 8.3 (inset) also shows that LUMO lies on the cross-linked tyrosine, such that upon 
reduction from PM → PR, cross-linked tyrosine would act as an electron acceptor, in conjunction 
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with the similar previous observations on the aa3-type oxidases [21].
Figure 8.3 Spin density distribution in the proposed PM intermediate in the catalytic cycle of C-type oxidases. Iso-
contour plots are drawn at the value 0.005 e/Å3. Blue and red are the excess α and β spin densities, respectively. The 
α density values are also listed for some specific moieties. Inset shows the presence of LUMO on the cross-linked 
tyrosine (Isocontour value: 0.05 e/Å3 ). Atoms are shown in the following colours: C (cyan), H (white), N (blue), O 
(red), Fe (green) and Cu (orange). Only hydrogens attached to N and O are shown.
A highly conserved tryptophan forms a neutral or cationic radical in the catalytic reaction 
of peroxidases [358]. It makes stacking interactions to the heme and its axial histidine ligand in 
addition to a  strong hydrogen bond with an aspartate.  All  these interactions in combination, 
modulates the electronic and geometrical structure of the whole system [160]. Although a similar 
structural  arrangement  does  not  exist  in  the  cbb3-oxidases,  preliminary  calculations  on  the 
extended  cluster  model  does  show  the  spin-density  distribution  on  a  distant  tryptophan 
(CI:Trp400) (Figure 8.4). This tryptophan along with another (CI:Trp341) hydrogen-bonds with 
the proximal glutamate, but do not form any other interactions with the heme or histidine (Figure 
8.4). The conjecture that tryptophan may play a role in electron transfer would require further 
experimental and computational studies. However, the high sensitivity of spin density on the 
dielectric constant support that the cross-linked tyrosine is the potential electron donor in cbb3-
oxidases too.
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Figure 8.4 Spin density  distribution in the  PM intermediate.  The extended active site  model  is  based upon the 
recently solved crystal structure of cbb3-oxidase from P. stutzeri [43]. Isocontour plots are drawn at the value 0.005 
e/Å3. Blue and red colours represent the excess α and β spin densities, respectively. C (cyan), H (white), N (blue), O 
(red), Fe (green) and Cu (orange) atoms are shown along with hydrogen bonds as blue dotted lines. 
8.3 Proton-loading site: pKa calculations
The proposed proton pumping mechanism in the A-type CcOs require a transient proton-loading 
site (PLS) from which the pumped proton is eventually released into the P-side of the membrane. 
The additional requirement for this site is that its pKa should modulate with the changes in redox 
state of the metal-centers and its interaction with the proton consumed at the BNC [21,98,136]. 
Previous  thermodynamic  assessment  of  the  catalytic  reaction  of  A-type  CcO, in  addition  to 
independent computational studies, suggested that the A-propionate of high-spin heme is the 
PLS [21,137]. However, explicit variations in its pKa due to the changes in redox states have not 
been observed. 
MD simulations combined with pKa calculations identified that the A-propionate shows 
high  proton  affinity  (pKa  ca. 10)  upon  dissociation  from  the  hydrogen-bonding  partner 
AI:Asp364  ('open'  conformation).  In  contrast,  when  the  two  are  strongly  hydrogen  bonded 
('closed'  conformation),  pKa of  propionate  is  much lower.  Additionally,  during the relatively 
short MD simulations of 5 ns, the open/closed conformations of A-propionate are found to be 
redox state dependent (publication IV). In the PM state with heme a reduced, multiple closed ↔ 
open transitions are observed, whereas no such transitions are observed in other states such as 
PR. This study suggests that A-propionate is the transient PLS in the proton pumping mechanism 
of CcO. 
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The proton affinities of a larger set of residues have also been calculated from different 
redox  states  by  averaging  over  the  snapshot  structures  obtained  from the  equilibrium  MD 
simulations.  Although longer  MD simulations or rigorous free energy calculations would be 
required to sample the large phase space and to obtain accurate estimates of energetics of redox 
dependent transitions, the increase in proton affinity of A-propionate upon 'opening' support the 
earlier proposals that reduction of heme  a is linked with the proton-uptake [67,68,69,86,135]. 
Thus, A-propionate of high-spin heme could be the proposed PLS, in that it accepts a proton 
from the D-channel end point AI:Glu242. Furthermore, since region around the A-propionate is a 
complex network of hydrogen-bonds, it can be assumed that the charge of proton is distributed 
throughout the region rather than residing fully on the propionate itself.
Instead of an aspartic acid an asparagine (CI:Asn333) makes a hydrogen bond to the A-
propionate of high-spin heme in the cbb3-type oxidases [43]. The A-propionate ↔ Asn system 
could thus be assumed to fluctuate in the same way as the A-propionate ↔ Asp system does in 
the  A-type  oxidases.  If  it  does  occur,  then  a  similar  increase  in  the  proton  affinity  of  A-
propionate  could  be  expected  (publication  IV).  pKa calculations  performed  by  mutating the 
aspartic  acid  into  asparagine  in-silico, in  both  'closed'  and  'open'  conformations,  led  to  an 
equivalent increase in the pKa of propionate, which suggests that the same region could form the 
PLS in the C-type oxidases as well. A more intriguing picture emerged when MD simulations 
and pKa calculations were performed on the cbb3-structure as described in the next section.
8.4 Water networks in cbb3-oxidase: MD simulations and pKa calculations
It is well-known that both A- and C-type oxidases catalyse the reduction of molecular oxygen to 
water and convert the free-energy into proton pumping. Even so, proton pumping stoichiometry 
in the latter enzymes is still a subject of debate. It has recently been suggested that the C-type 
oxidases pump protons at nearly half the stoichiometry reported for the A-type enzymes [144]. 
However, this finding contradicts the view that C-type oxidases are highly efficient enzymes and 
are capable of 1 H+/e- pumping stoichiometry even under low-oxygen tensions. Notwithstanding 
the stoichiometry, the proton transfer pathways must be present in the catalytic subunit of C-type 
oxidases in order to supply protons either to the BNC or to the PLS. Earlier homology models  
and site-directed mutagenesis studies identified a proton channel in the region analogous to the 
K-channel of the A-type oxidases (publication I) [156]. Recent crystal structure also confirmed 
the presence of this proton channel [43]. However, this path does not complete the connection to 
the P-side of the membrane, which would be essential for proton pumping. In publication VI, a  
proton channel is identified in the catalytic subunit of cbb3-oxidase from P. stutzeri, which may 
be utilized for redox-coupled proton pumping. 
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The work is based on three different computational approaches; DFT calculations, MD 
simulations and continuum electrostatic calculations. Since MD simulations on oxidases require 
partial  charges  of  metal  centers,  ESP based  charges  were  obtained  after  performing  DFT 
calculations on the cluster models (publication VI). This type of approach has successfully been 
used before, on variety of enzyme systems [359,360,361]. Test calculations were also performed 
in order to gauge the variation in charges with different methods available in TURBOMOLE. 
For instance, a change in the dielectric constant from vacuum to 4 did not alter the charges to a  
greater extent. In addition, increasing the density of points in the ESP calculation had a smaller 
effect on the charges. Moreover, qualitative comparison of the obtained charges show similarities 
with the standard CHARMM charges especially for the  b-type heme and glutamate residue,  
which corroborates the process used here. It has previously been argued that ESP based charges 
of buried atoms are not accurate [336], nevertheless, in the current study most of the results are 
compared between different redox states, hence,  such errors would most likely have a small 
effect.
The  continuum  electrostatic  calculations  were  performed  on  the  crystal  structure  in 
addition to the snapshots structures obtained from MD simulations. Figure 8.5 shows the surface 
representation of electrostatic potential in a fully oxidized state of the enzyme. Although proton-
affinities of a larger set of residues were obtained, two residues distinctively showed deviant 
profiles. First, histidine (CI:His337) displayed high pKa in all the studied redox states. CI:His337 
is located near the P-side of the membrane and hydrogen-bonds to the A-propionate of high-spin 
heme (Figure 8.1D and 8.6B) (publication I) [43]. The high proton-affinity of histidine in the C-
type oxidases contrasts with the A-type oxidases in which the analogous histidine cannot be 
protonated due to its ligation to the redox inactive metal center (Mg+2) [69]. On the other hand, 
the corresponding histidine in B-type oxidases is likely to be protonated due to its interaction 
with a negatively charged residue in the region [29], whereas no such interaction exists in the C-
type  oxidases  [43].  The  protonated  histidine  would  neutralize  the  negative  charge  of  the 
propionate in the crystal structure conformation. However, considering the fluctuations observed 
in the hydrogen-bonding between the histidine and the propionate during the MD simulations, it 
can be inferred that this region is likely to be a PLS region (publication IV), and dissociation of 
the hydrogen bond between the two may increase the proton affinity of the latter.
Second, the proximal glutamate (CI:Glu323, Figure 8.6A and 8.6B) shows protonation 
upon the reduction of heme b3, whereas it may or may not be protonated when heme is oxidized. 
The hydrogen-bonding of  glutamate  to  the  histidine  ligand  of  heme is  a  unique  interaction 
known only in the C-type oxidases, and the observed protonation profile implicates a redox-
coupled protonation mechanism. Moreover, since redox potential of heme b3 is uniquely low (-
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60 mV), it  is  likely that  protonation of proximal  glutamate tunes  the redox potential  of  the 
former  to  allow  its  reduction,  which  would  be  a  proton-coupled  electron  transfer  kind  of 
mechanism.
Figure 8.5 The two subunit C-type oxidase from P. stutzeri is shown in the ribbon representation (left). Subunit I in 
blue and subunit II in the red colour. Hemes are shown in yellow and copper in orange. The surface electrostatic  
potential representation in the fully oxidized state is also shown (Right). Blue corresponds to +5 kT/e and red, -5 
kT/e.
The  MD  simulations  were  performed  on  the  water-loaded  two  subunit  enzyme  in 
different redox states. Water molecules were predicted inside the protein interior by using the 
interaction energy approach as available in the DOWSER program [350]. Since this approach is 
based on crudely  parametrised van der  Waals  and electrostatic  energy interactions,  different 
energy  cutoffs  were  applied  in  order  to  analyse  the  water  density  inside  the  protein.  More 
sophisticated thermodynamic based approaches of water prediction, which have previously been 
used in the A-type oxidases [83], have not been used here. 
Multiple simulations of 5 ns each in different redox states showed the formation of water-
chains inside the protein interior. The water-chain at the location analogous to the K-channel of 
A-type oxidases formed irrespective of the redox state or different energy cutoffs used for water 
prediction (Figure 8.6C). This stable water chain thus enables continuous supply of protons to 
the BNC for oxygen reduction chemistry to occur. Another water-chain is concurrently observed, 
which  connects  the  N-side  of  the  membrane  to  the  proximal  glutamate  (CI:Glu323),  and 
glutamate to the histidine-propionate pair (Figure 8.6A and 8.6B). This pathway could be used 
for  redox-coupled  proton  pumping  in  the  enzyme.  The  stable  water-chains  lead  to  the 
identification  of  certain  amino  acid  residues  which  may  be  important  for  proton  transfer 
reactions.  This  result  requires  site-directed  mutagenesis  studies  in  order  to  confirm  the 
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predictions made here.
 
Figure 8.6 Hydrogen-bonded water chains in the C-type oxidase. A) Water-chain connecting the N-side with the 
proximal  glutamate  (CI:Glu323)  and,  B)  proximal  glutamate  with  the  A-propionate  region.  C)  Water  chains 
connecting the N-side with the active site of oxygen reduction (BNC). Water molecules are marked with a prefix W. 
Amino acid numbering corresponds to the crystal structure of C-type oxidase from  P. stutzeri [43].  C (cyan), H 
(white), N (blue), O (red), Fe (green) and Cu (orange) atoms are also shown along with hydrogen bonds as purple 
dotted lines. Only hydrogen atoms connected to N and O are shown. Figure 8.6 is published after permission from 
the publisher.
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Chapter 9
Conclusions and future directions
The thesis work highlights the importance of computational methods in studying the structure 
and function of an enzyme. Computational methods not only help in providing a molecular basis 
to the experimental results, but also allows the generation of new hypotheses, which can be 
tested  with  both  experimental  and computational  methods.  However,  at  the  same time it  is 
important to be aware of the limitations of computational approaches.
Homology modelling successfully predicted the correct location of cross-linked tyrosine 
and a proton channel in the C-type oxidases, which is impressive especially considering the low 
levels  of  sequence  identities  (ca. 20%).  However,  it  is  realized  in  the  work  that  manual 
adjustments in the alignment or other refinements in the models should be done with extra care. 
DFT calculations on cluster models of active-sites provided molecular level interpretation to the 
EPR experiment results. In addition to that, they also described the structural reasons for the 
high oxygen affinity  shown by the  C-type  oxidases.  Such proposals  can  be confirmed with 
further experimentation and modelling.  Additionally,  continuum electrostatic calculations and 
MD simulations on the C-type oxidase led to the identification of amino acid residues which 
might be important in redox-coupled proton transfer. These predictions can be analysed with 
biochemical methods such as site-directed mutagenesis approaches.
The recently solved crystal structure of C-type oxidase has opened up new avenues for 
the computational biochemistry field, such that many different computational methods can now 
be applied. Advanced methods including free-energy calculations or QM/MM calculations will 
be  used  to  understand  the  electron  and  proton  transfer  reactions  in  the  enzyme.  Direct 
comparisons can be made to the well-studied A-type oxidases, which would help in identifying 
both the differences and the similarities between the two. It is of general importance to identify 
the minimal functional elements that would constitute a proton pumping machine.
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